iTrackr.com (OTC BB: IRYS): Site Launch Has Shares Flying

First Is Not Always Best

Analysts love the phrase “First Mover Advantage”, but first is not always best. The first mover in the online coupon world has been highly publicized and controversial Groupon (NASDAQ: GRPN).

The company had humble beginnings. It started with a small email distribution list. It offered a “Flash Sale” discount. What was offered? A half price pizza at a restaurant located in the fledgling company’s office building. Lots of people showed up for pizza, and a new concept was born.

The concept expanded in the Chicago area, and Groupon looked to go national. With $1 billion in financing from a Venture Capital group, Groupon started buying up Daily Deal services in larger cities all over the world, and became the fastest company is history from its birth to achieve $1 billion in annual sales.

Groupon has first mover advantage and a global footprint. But first is not always best. The best is always the one consumers like the most. Do they have the best model for the consumer?

Consider the history of First Movers in the internet space. How about the early behemoth AOL. AOL was able to swallow up Time Warner in the rah rah days of the 90′s as the market believed the AOL model would dominate online browser, shopping, and communications.

However, AOL only allowed users to see what they wanted you to see, and there were subscription fees. This closed community failed miserably, and AOL lost its dominance and retreated into oblivion.

AOL was knocked of its pedestal by Yahoo! (NASDAQ: YHOO). Their open community and free services destroyed the AOL model. The Yahoo! community grew rapidly, and opened access to a lot more content on the internet.

However, as it turned out, Yahoo!’s model was flawed as well. Yahoo’s! search service only allowed users to find content if the content provider paid Yahoo! an advertising fee. Yahoo! failed to see this approach was vulnerable.

Google (NASADAQ: GOOG) came along, and with its completely open search features and superior technology, wiped out Yahoo!’s dominance in search.

The ever growing population of internet users doesn’t want their experience to be controlled by anyone or anything. Consumers of goods, services, and information want what they want, not want they provider wants to cram down their throat.

They say one picture is worth one thousand words. I say one chart is worth millions of dollars. Here’s a chart that says it all. This chart shows the relative performance of AOL, Yahoo!, and Google since the 2008 market crash.

AOL, the “First Mover” with the most flawed model, is depicted in blue and clearly the worst performer. Yahoo!, the upstart that wiped out AOL, is shown in Black. This stock has done poorly as well.

Google is depicted in red, and its by far the best performing stock of the group. Google was last to the party, but has the best model for the consumer.

This chart provides definitive proof that early entrants with a new business concept don’t necessarily offer the best model for consumers.

Look out Groupon- there’s a new kid on the block about to knock you off. Read on…..

iTrackr (OTC BB: IRYS): The Power of 15 Million and 200 Million

Data, when properly used, is powerful stuff. Data, simply defined, is information. Websters defines “DATA” as individual facts, statistics, or items of information.

iTraker (IRYS) has lots of data, and therefore lots of power- IRYS has 15 million items of information in one category, and 200 million in another category. The company intends to marry the two, and provide consumers with the discounts they really need and want.

200 Million is the number of records IRYS has already obtained on individual consumers. The data includes names, email addresses, street address, demographics, and spending preferences.

15 Million is the number of records IRYS has on businesses in the US. The IRYS service officially launched this past weekend, and you can go to www.itrackr.com, set up your username and password, and start negotiating your own deals with your local merchants.

iTrackr has introduced the first web based platform that allows consumer to interact directly with local merchants onlne.

The screen shot on the right is the home page where you can go to register. Merchants and consumers alike can set up their profiles, and the platform can join the two together.

Merchants will have the ability to reach to local consumers with a special offer.

Consumers have the ability to ask for a discount from businesses on the site.

Unlike Groupon, the merchant collects the money from the customer, rather than Groupon collecting the money and stretching the merchants out 60 to 90 days to get paid.

As an example- let’s say you want to take in your dry cleaning tomorrow. You log in to the site, go to your map, click on the proper service button, and all the local dry cleaners in your area come up with icons.

You simply click on the ones you want to do business with, and ask for a discount. The merchant can then respond by accepting, declining, or making another offer.

With Groupon, only Groupon wins. With iTrackr, everybody wins. 

Make Your Deal

I wanted to show you one additional screen shot. This is the interface that allows you to try to make a deal for a coupon with a local merchant.

This is a map of my neighborhood. The icons on the map show some of the local restaurants. I clicked on the icon for my local Ruths Chris Steak House. I now have the option of requesting anywhere from a 25% to a 70% discount on my next visit.

Once I’ve decided on my offer, the interface will send a message directly to the restaurant on my behalf.

Ruths Chris then has the option to decline my offer, accept it, or counter with a different offer.

Ruths Chris now knows I’m a consumer interested in their restaurant, and they now have the ability to reach out to me through the iTrackr.com interface with future offers.

From the current levels, if the company makes money, there’s little doubt you will make a lot of money on the stock. So, how does IRYS generate revenues?

Lest you think differently, IRYS is no start up. In order to introduce their platform, this company needed to have deep seated roots in internet marketing.

The first generation of the iTrackr.com model allowed consumers to find local merchants with hard to find items in stock. That version of the service was spun out in the 2008 recession, but eventually was developed and sold to eBay for $90 million.

The company is building its new platform off a rich heritage of behemoth customers that currently pay IRYS in monthly fees. Saveology, a $1 billion digital marketing company you never heard of provides customers for companies like:

  • Cox Cable
  • Verizon Wireless
  • Time Warner
  • Comcast
  • ATT

An IRYS application is embedded in online marketing sites for all these companies, and this service generates significant revenues and allows IRYS the leverage to launch a platform robust enough to manage the records and transactions for 200 million consumers and 15 million small businesses in the US.

Once launched, IRYS will generate revenues from the businesses- not from consumers. Businesses who enroll in the program will pay a nominal monthly fee to be included in the interface. Fees will range from as low as $14.95 to $39.95 per month depending on how pro active the business owner wants to get with IRYS and its local customer base. It’s far cheaper than a Yellow Pages ad, and allows for direct contact with local customers. This could end up being the most cost effective advertising any local merchant has.

Where To From Here?

I suspect IRYS is going to explode between now and the end of March. Why? The company is focused on uploading the most valuable parts of its 200 million record consumer database, and 15 million record business database. IRYS will focus on businesses with the right SIC codes for local merchants, and consumer in certain high density parts of the country.

The site went live this past weekend, and a look at the chart gives you an idea of how market investors feel about the upside potential of this new platform.

I suspect the chart and the useage level of the site will track each other. So, as local businesses and consumers all over the country slowly realize there’s a win/win competitor for Groupon, buyers are likely to flock to the stock as they adopt the service.

Consider that IRYS already has hundred of thousands of sign ups from the first version of it’s online service, and people are now coming to the site in droves and signing up.

The key to making the dream returns of a lifetime in a situation like this is getting in early- getting in before the crowd realizes robust nature of the service and the substantial growth potential.

By the summer consumers will be telling all their friends about a web site that allowed them to ask for a discount at 5 different local dry cleaners, and how they got a 25% discount from the one that replied.

The platform is still in development, and won’t be finalized and really robust for several months. There’s going to be a major initiative to enroll businesses as subscribers.

This new service is what the Internet is all about. It’s getting information and saving money and time quickly and efficiently. It’s surprising no other company has launched a service that allows consumers to negotiate discounts with local merchants, but perhaps no other company has ever had access to the data that can marry both sides of the equation.

Today, IRYS only trades in the $.70 to $.80 range. There’s massive upside as the company grows and the stock moves higher. This is the kind of stock investors want to accumulate before the word gets out.

I believe the stock has the potential to easily trade into the $1.50 to $2 range over the next 2 to 3 months, and a $5 target price is possible long term as iTracker’s service gets widely adopted by consumers and merchants. The possiblity of 100% to 500% returns on this stock in 2012 are very real.

Get into this stock ahead the millions of other investors who will learn about over the coming days.

Full disclosure- I am a shareholder in this company, and I invested in a substantial number of shares with my own capital. You should view my ownership in shares of IRYS as a potential conflict of interest. Beyond that, I have no business relationship with IRYS. I simply believe we can make money on this idea.

I could be buying and/or selling shares at anytime, so keep that in mind. I’m hoping to see the stock well over $1 with plenty of volume in the next several weeks.

Home Page : www.otcjournal.com

Email Questions or Comments To: editor@otcjournal.com

Penny Stock Exposure: Letting the Cat Out of the Bag

Letting the Cat Out of the Bag

You might be wondering what the heck is going on with the latest series of publications. It’s time to give you the full view so you’re dialed into the method behind my madness.

Of late, I’ve been referencing three, new, Big Ideas I’ll be delivering over the next several months- the first coming this Wednesday. I’ve also been showing you a marketing campaign featuring penny stock guru Timothy Sykes, which is not the sort of content I normally publish.

The two are intertwined. Let me explain.

2011 was one of the worst years I’ve ever had professionally. I spent the summer months of 2010 working on the launch of my www.emergingchinastocks.com subscription based site, and rolled it out in October of 2010.

After a few months of strong performance, the China small cap sector was decimated in a way I’ve never experienced in the 25 years I’ve been involved in small stocks. I didn’t understand the extent of the high levels of fraud being committed by Chinese companies on US investors. I lost a substantial amount of my own capital, and the service ended up having little value in the face of the tsunami of fraud.

If nothing else, after all these years I know I can make money in the small cap world. I’ve proven it time and time again. In order to reverse the tide, I turned my attention to 3 major new ideas back in the good old USA. I’ve been working on these projects since November, and my efforts are now coming to fruition.

I’m not giving up on the China small cap sector. I simply recognize there’s nothing to be done there for now. The truly great companies in the sector are trading rather listlessly, and as soon as they perk up, I’ll pounce on the solid opportunities that remain.

Exciting new companies come along regularly in today’s penny stock environment. While many of them have little or no audience, the technology exists to develop big followings for the favored few, and I’m going to put you at the front end of major awareness campaigns.

The Timothy Sykes offerings I’ve been publishing of late are all focused around the first of my 3 big ideas. Thousands of potential investors, through a number of publishers, have signed on to learn about the first pick, and you’ll be learning the symbol the day before most of them.

The truth of the matter- I need to make a lot of money this year. I need to make up for last year’s extensive losses. I’ve taken three major positions. I’ve put my own capital at risk.

While I have no contractual obligation to cover any of these names with OTC Journal subscribers, I’m going to- because that’s what I do.

Wednesday’s first idea will feature company that has the potential to revolutionize the way consumers interact with local merchants. The Groupon model is doomed unless the company makes some major changes.

Here’s a phrase I’ve coined that sums it up:

With Groupon, only Groupon wins. With xxxxx, Everybody Wins.

This new company just launched an interface that marries consumers to merchants in a new and unique way, and it is growing and evolving everyday. This company is already providing technology services to the likes of AT&T, Time Warner, Comcast, and many others. It’s no start up.

On Wednesday, you will learn just who xxxx is, and what they do.

In the meantime, if you want to follow the Sykes campaign, here’s the today’s content. If you have an interest, sign up and go through the process. Sykes is a pretty bright guy in this sector, and has a big following.

His involvement gives us a really strong possibility for a great short term surge in this stock simply because in the early going, there will be more buyers than sellers.

I have a pretty substantial position in this stock that I’ve acquired by putting my own capital at risk, so you should probably view that as a potential conflict of interest. If you decide to invest, I might be selling you the stock you’re buying.

In this case, I’m not in a hurry to sell this week- I expect higher levels and better volumes over the next 3 to 4 weeks, so I plan to be rather stingy on providing my shares to the market. Nevertheless, you should view my position as a potential conflict.

Here’s the next installment of the Sykes campaign which you might find interesting and informative.

NEW VIDEO: Big Trade Lining Up

If you like the idea of trading stock promotions (those marketing campaigns that Tim Sykes showed recently that drove stocks up 280% gain in 14 days… 642% in 42 days…and even 1,540% in 21-days in 2011)…

…then Tim’s new video is going to rock your world, because he says another trade is lining up.

The Best Part: Tim—who spent 3 years as a #1
rated hedge fund trader—is going to take you step-by-step through trading one of these promotions LIVE and with REAL MONEY, so you know exactly how to play these promotions.

Click here to get Tim’s latest video.

http://60day-trial.com/?aff_id=4294

Just the other week, one of Tim’s students, a college kid, used one of Tim’s alerts on a stock promotion to make 108% in 1 day, without leverage, from his smartphone while waiting in line at the Department of Motor Vehicles.

Remember, Tim has a long history of major successes as a trader, including: In 2007, he was named one of Trader Monthly’s top 30 traders under 30. He turned $12,415 of Bar Mitzvah money into $1.65 million in four years before he graduated from college, and then grew it into $2,730,000# Yes, you read that right, he published his broker statements online to prove it.

Barclay Rankings, the hedge fund ranking company, rated Tim the #1 short-bias hedge fund for three years running, 2003-2006, while he still ran his hedge fund. PLUS…

Tim’s been ranked the #1 trader out of 60,000 traders on Covestor—a website that verifies trades and performance—over the last four years.

When the market crashed in 2008, he still ended his year with a 197% GAIN.

Since 2008, he has helped members in one of his trading services generate a verified $1.7 MILLION in profits. In a second service, he has helped regular investors generate $1.5 MILLION in profits.

So Tim’s not only a great trader, he’s a great trading teacher as well.

If anyone can help you take your trading to the next level, Tim can.

Now he’s offering to take you, step-by-step, through trading a real, live, stock promotion as it unfolds. Just click here to get all the details.

I wouldn’t put this off because you don’t want to miss out on the trades when they come through.

Check out the video now.

http://60day-trial.com/?aff_id=4294

All my best,

Larry Isen


There’s today’s installment. One more tomorrow, and off we go on Thursday.

Home Page : www.otcjournal.com

Email Questions or Comments To: editor@otcjournal.com

 

 

“CALL GOOD To US”- Three Monster Pennies Coming

The “CALL” Has Been Good To Us

Mark it on your calender- the week of March 12th. My big win for 2012- the March 15 CALL options recommended in early January at $1.40 needs to be liquidated before that week. Here’s why.

This is a good one for your market experience “hard drive”- burn it onto your mental disc drive. When a stock runs up into an earnings release, 99% of the time it will sell off immediately after the news comes out. The one exception would be Apple Computer (AAPL)-the company absolutely blew away analysts estimates and the stock went up.

I called this perfectly on Baidu (BIDU) last week- choosing to suggest to subscribers at www.emergingchinastocks.com they sell covered calls against their position on the earnings news. Kaching- 65% gain in 3 trading days.

As you can see from the chart, the stock had traded up beautifully into earnings. The company beat the estimates by 10% on a strong top line, then the stock sold off 4 consecutive trading days before heading back up.

This happens when hot, short term money makes a bet on an earnings surge a month or two ahead of earnings, then looks to harvest profits when the news comes out.

In the case of the Magic Jack (CALL) Call options I recommended at $1.40- they are now trading at $3.50- down from their high of around $5. Today, it’s 150% return in 6 weeks- not bad.

Magic Jack (CALL) has announced it will release Q4 and year end audited results the week of March 12th. These options expire on March 16th. The time value is eroding on these options, and the stock will likely sell off after the news comes out.

Therefore, you would be well served to be out of these options by the end of next week of the latest, if not earlier. If the stock has traded up or remains close to the $20 level when the numbers come out, I will suggest a quick trade on the short side to take advantage of the inevitable sell off. If you see the stock approaching the $20 level, sell immediately. That will likely be the ceiling in the short term.

The First of a Blockbuster Trio

As alluded to in previous editions, I’ve been working on 3 incredibly strong penny stock opportunities, to be released consecutively over the next 3 months. These are a different breed of cat from the few hit or miss, quick trade ideas I’ve delivered this year.

On these 3 ideas, you will have a “First Look” out in front of millions of investors who will learn about these three ideas a week or two after you get the “first look”. There will be lots of follow up on these ideas.

I’ll be releasing my first “Monster Idea” next Wednesday, and you’ll want to be first to make a trade ahead of the rest of the world. Here’s a little preview:

Groupon (NASDAQ: GRPN) has been highly touted as the company to get to $1 billion in revenues faster than any company in history. I guess $1 billion in revenues ain’t what it used to be.

I believe the entire Groupon model is fatally flawed, and unless the company makes some changes, this ship is destined to sink. The market is catching on as well – the stock is now permanently camped below its IPO price.

There’s problems on both the user and merchant side. Speaking as a user, I can’t recall the last time Groupon notified me of any “flash sale” on any item I was actually interested in purchasing. Every day it seems like I’m bombarded with a myriad of offerings that include bikini waxes, yoga classes, and tanning beds. I have zero interest in any of those offerings.

On the merchant side, Groupon is getting the bottom of the barrel. When you “pre pay” Groupon for a 50% discount at a restaurant, Groupon keeps half the money, and sends the other half to the merchant in about 90 days. Therefore, only the most desperate of merchants are using the service in most cases.

Groupon does have the largest network, so there’s value in their ability to distribute. However, this model is doomed. Without adjustments, Groupon will go the way of many of the early entrants into explosive digital markets- does anyone remember Netscape, AOL, or MySpace? All early entrants with flawed models.

Move over Groupon- the first online site that creates a direct interface between consumers and local businesses is about to launch, and it will allow the consumer to reach out to local merchants and negotiate a discount in advance.

For example- you could pick 3 dry cleaners in your neighborhood, ask for a 25% discount between from any or all of the 3, then go wherever they will work with you. For me- this has value.

Stand by to learn more next Wednesday. I’ll have more early next week.

Home Page : www.otcjournal.com

Email Questions or Comments To: editor@otcjournal.com

Uranerz Energy (URZ): Forgotten Commodity Rocking

Oil, Gold, Copper, Silver- it’s all any commodity player can talk about. However, there’s another commodity the main stream media is ignoring. Why- I’ll tell you why- It’s because the big boys on Wall Street are accumulating their position before they let their secret out to the public through the talking heads of Wall Street media.

When Cramer goes on his Mad Money show and tells the suckers of the world it’s time to buy Uranium and Uranium stocks, he will be acting as a puppet for the big boys who already own it cheaper than you. Where do you think these “journalists” get their stories? From Hedge Fund Managers with positions must cheaper. They use the Cramers of the world to create an exit strategy.

So – what is this forgotten commodity? Glad you asked- it’s Uranium- nuclear fuel. A big run in Uranium was sabotaged in 2011 by the Japanese Tsunami- who could forget the imminent threat of a nuclear melt down in Japan? All of a sudden, the world lost its enthusiasm for building nuclear power plants. So, where is new demand coming from?

Nuclear In China – All the Rage

Coal is the only cheap commodity in China, and the Chinese are trying to reduce pollution and diversify into other forms of energy.

Mainland China currently has 14 nuclear power reactors in operation. 25 more are now under construction, and more are about to start construction soon.

Additional reactors are planned, including some of the world’s most advanced, to give a five- or six-fold increase in nuclear capacity to at least 60 GWe by 2020, then 200 GWe by 2030, and 400 GWe by 2050.

This aggressive build out by the Chinese has led to massive new demand for Uranium for the foreseeable future.

Over the last two months Uranium has quietly sneaked up from $40 to $53- heading back toward’s its high of about $110 per pound pre 2008.

Uranerz Energy (AMEX: URZ): Recent Drilling Programs Have Stock on Fire

Uranerz Energy is absolutely on fire. Coming off a severe low last October of $1.40, the stock recently ticked up to $2.85 and is looking higher nearly every day.

URZ has been drilling in Wyoming’s prolific Powder River Basin. 6 uranium exploration holes were drilled to a total of 140,000 feet, with three drill rigs in place. Last week the company reported the best drill results to date from the nose area of the Nichols Ranch deposit that were even better than had been expected. URZ had resources of over 19 million pounds of U3O8 as of October 14, 2010.

According to a recent press release as it relates to their mining operations: ” Construction is well underway and is currently on schedule. The Company’s focus is on the construction of the processing plant, the office and laboratory, the maintenance facility, and the installation of monitor and production wells required for ISR uranium mining. Six drill rigs are engaged in production well installation.”

This company is fully underway- mining and processing are in place, and the Chinese are knocking on their door.

Is it any wonder the stock is behaving so well?

A quick look at this chart shows me a stock that has traded nicely in 2012, but has a long ways to go.

URZ has been in a solid up trend since December as the price of Uranium started to surge once again.

URZ is owned by 10 large institutional holders, and 10 different mutual funds.

The stock is part of the Russell family of indexes- specifically the 3000, 2000, Global & Microcap.

URZ trades, on average, 517,000 shares per day, and as you can see the chart looks absolutely outstanding.

As demand for Uranium continues to expand, and URZ moves further down the road with harvesting Uranium from its Power River Basin operations, there’s no reason this stock couldn’t at least go back to its 2011 high of $6- before the Japanese Tsunami caused an unwarranted sell off in Uranium stocks.

I like URZ for at least $3.50 in the next week or two, and much higher levels over the coming months. This one is not just a trade- this is a good long term hold for your small cap, commodity oriented portfolio.

Uranium is the forgotten commodity. When Cramer is talking about this one again, you’ll know it’s too late. Accumulate while this one is still relatively under followed, then sell when Cramer tells everyone its safe to buy.

Facebook Madness Drives OTC Journal Winner

It’s nice to be right even if it takes a little longer than anticipated. 2011 followers should remember, and hopefully still have shares of video ring tone company Vringo (AMEX: VRNG)- a stock I featured in about 6 editions just a few short months ago.

My first edition on this company was published on Sunday, May 1st, and over the course of last year I wrote about 6 editions on the company. My first edition was at $1.40, and the stock found its way to $2.60 for a 44% gainer in 7 trading days.

The stock then fell on some hard times as they had some issues meeting their listing requirements with AMEX, but that is all behind them now.

VRNG has very clever video ring tones that are being adopted globally and now available to millions of mobile device users. The stock has gone nuts over the past few days as a result of the Facebook ap, and all the hoopla surrounding the pending Facebook IPO.

Their ap is very clever – here’s how it works. You call your buddy on your smart phone. You both have the Facebook ap installed. While you are talking to each other, you see his latest Facebook pictures roll by on your screen, and he sees your latest pictures as well.

Their revenue model is clever as well. You can get the AP one of three ways. You can buy it for $2.99 permanently, pay a monthly fee of $.99, or get a free version that allows advertising. Very clever.

Last I checked, the AP was available through Verizon for most mobile phones, but I’m not sure if the iPhone is included yet. If not, it will be.

This stock becomes one to watch as one of the only companies that has a killer Facebook Ap. As you can see from the chart, the stock went absolutely nuts out of the blue this week, and as we get closer to the Facebook IPO, could go even crazy. Probably a good one to accumulate on dips.

January Updates

Here’s a recap of the January ideas.

  • Liberator (LUVU)- introduced at $.15- closed at $.20 on Friday, off a high of $.24. 33% gainer based on Friday’s close. Still looking for momentum and much higher levels.
  • Frog Ads (FROG)- January’s introduction at $.30- Friday’s close at $.27 on nearly 1 million shares of volume. 10% loser, and on support- a good level for a trade right now.
  • Magic Jack (CALL) $15 March calls at $1.40- closed Friday at $3.10- up 121% – a giant winner.
  • Dexcom (DXCM) $10 March calls at $1.40- closed Friday at $1.80 for a 28.5% gain.

That’s 3 for 4 in January, with the giant win being the Magic Jack Calls up 121%.

One For Two This Week- Updates on CALL and FROG

FrogAds (OTC: FROG) did not jump for us as I had hoped this week, but hang on for a bounce. From $.30 to $.28 is not a big deal. I suspect $.25 will be support for this one, and you might be well served to file a limit order with a tight stop to hop back in at $.25.

I’m not sure we’ll get there, but if we do, that might be great level for easy money. The stock has not traded below $.24, so $.25 would be a great level to accumulate for the next bounce. Volume is coming down, which suggests the sellers are exhausted. The lower the volume from here forward, the more I like $.25.

Of the two options ideas I provided last week, one is just ripping to the upside, and the other is a break even. My Call on Call is climbing everyday, and this stock looks to me to have major upside potential even from here. It is clearly breaking out, and there are no sellers to be found anywhere.

CALL is the company that makes and markets the Magic Jack product you see advertised everywhere. $17 for a year’s phone service. Investors I know who follow the company tell me their new generation of technology is far superior to their first version, and as a result they are expecting Q4 and year end results to be very strong.

The stock is behaving as if institutional investors believe it as well. This scenario is what I call an “Event Driven Trade”. The event- a big earnings surprise to the upside. The trick- knowing how to trade it.

The key to trading a stock that moves much higher into earnings is to sell either just before the earnings release, or in the first half hour of trading after the earnings release.

Since the OTC Journal is committed to low priced stocks, I recommended the March $15 call options at $1.40. Today they are $2.25 for a gain of 60% in one week.

I don’t believe this stock has peaked. Any correction should be used as an opportunity to add to or open your position.

FROG Poised To Bounce

As Promised- A Changed Approach

In my first edition of 2012 I promised a different approach to penny stock coverage. I promised no more one day wonders. I pledged to stick with each idea for a month or two and provide some follow up. I don’t believe the penny market is well served when newsletters give 3 ideas a week. They tend to blip up so temporarily it’s almost impossible to make a profitable trade, and then a day later it’s on to the next idea.

I’m determined to get a little more old school this year, and try to get you out in front of stocks that you can jump into when they are cheap, and sell when they rally. I’ll try to position us to have the time to take a profit in these ideas, and deliver ongoing coverage. Today is my third edition on FROG.

I hope you are watching my idea on March 15 calls on CALL closed at $2 offer- that’s up from $1.40 late last week, and looking better every day. This is the kind of idea you have some time on. LUVU hit $.24 today in the early going, which is a new post coverage high, but then gave some ground late in the day. At yesterday’s close, the stock is still 23.5% above the entry level earlier this month, and looking to get even better.

I’m 2 for 2 on entry levels for FROG-and today is follow up #3, as pledged. I believe this model will serve you- the penny stock investor- far better than the 2011 model of 1 day wonders.

And, speaking of the FROG- another surge up, another pullback, and another good entry level. Technically, now is the time to jump back in if you’re game. Check out the chart……

FrogAds (OTC BB: FROG)- The Lows and Highs Are Getting Higher

I called the last FROG bounce at $.30, and it bounced to $.40 in two trading days. If I had suggested you pick up a stock at $30, and you could have sold it two days later at $40, you would think it was the trade of a lifetime.

It’s the penny market, and investors don’t always see things that way. We all realize $.30 can go to $.20 in the blink of an eye as well, so there’s two sides to that pancake. Market makers generally trade these smaller stocks from a short position, so their agenda is usually to drive the stocks down. They realize a short sighted penny stock trader can be spooked out rather easily, making for easy money for market makers.

Back to FROGads. The success of this company is 100% related to the amount of traffic and popularity of their newly launched site. Last night I decided to do my own research, and get some traffic reports on www.frogads.com.

Most internet analyst will look at the Alexa ranking, which are a bit like the Nielsen ratings of internet sites. WWW.Alex.com follows browsers around the internet through an embedded tool. It’s a bit like a Nielsen box on your TV. However, Alexa is flawed. Programmers have been known to create clever online robots designed to deliver exaggerated traffic ratings.

An alternate traffic service that is more accurate in my view can be found at www.quantcast.com. Quantcast requires the site owners to allow their service a certain level of access so traffic can be independently reported.

The company has not registered to be tracked by Quantcast, so we can only get limited traffic information there. In December, Quantcast reports the www.frogads.com‘s traffic was up 463% in December. This makes sense, as December was their launch. The Quantcast rankings have risen in the last week as well. It looks like the traffic to the site is growing about 2% weekly- which is huge on an annualized basis.

The action in the stock was telling yesterday. The stock had a big, low volume drop, but bounced generated a 60% rebound of the day’s sell off. This suggests the stock is going to bounce back again tomorrow, and perhaps another trade into the $.40 range is in the cards.

With the ranking services showing increasing traffic to the site, some level of success is inevitable at the company.

Yesterday the market makers tried to spook traders out of the stock by selling it down rapidly on low volume. It looks to me like either bargain hunters surfaced, or sellers just didn’t materialize as they had hoped, and they had to cover.

Look for the bounce to continue today, and perhaps there’s another trade here for $.40- a 33% jump from yesterday’s close if this is Deja Vu all over again. If you’re trader, get in early and keep a watchful eye.

Liberator (LUVU) Gets “Stern” For More Sales

Our Second Last “Pre Football” Edition

Are you ready for some football? To end? I’ve really enjoyed this theme- a Sunday morning edition prior to the NFL games. Only the Superbowl remains after today’s Championship games.

So, sit back, relax, and read this Sunday’s OTC Journal before Baltimore tries to handle Brady and New England, and the NY Football Giants head into San Francisco. Watch for the Niners- a great defense and a good running game can take you a long way this time of year. The Baltimore/New England game is a toss up. Baltimore does not play well on the road. Slight edge to the Pats there.

So, how about this past week? Four ideas so far this year, and here’s your update:

  • Liberator (OTC BB: LUVU) made a new multi month high this week, trading up to $.23 from the $.15 entry level. Post close news Friday on this one bodes well for Monday trading. A 53% gainer so far.
  • As predicted- FrogAds (OTC BB: FROG) jumped from $.24 to $.40 this past week- that’s a 66% move this week. I think that one could continue higher next week.
  • Dexcom March 10 Calls (DXCM) I recommended at $1.40 closed at $1.40- unchanged. DXCM is rumored to be a good acquisition target.
  • Magic Jack March 15 Calls (CALL) I recommended at $1.40 closed at $1.75- a nice 25% gain, but not even close to what I’m looking for.
  • Investors who listened to my caution warning on red hot penny stock North Springs (NSRS) might have been a little disappointed. I predicted it would drop 70% in one day, and it only dropped 60%. It did deliver the inevitable bounce, but I suspect the game is over, and the stock will head lower again.

That’s 4 gainers and 1 break even this week. If every week was this good. I can only hope. This market is really heating up. The market is not listening as intently to the noise out of Europe, and the economy is perking up nicely. With stocks this cheap, it’s a great time to get aggressive.

And, speaking of aggressive, did you catch Friday’s post close news on Liberator(LUVU)?- Off a new multi year high this week, it’s looking like another strong week might be in the cards. Read on McDuff………..

Liberator (LUVU) Gets Stern To Expand Revenues

As mentioned above, Liberator (LUVU) made a new multi month high this past week, hitting the $.23 mark. It’s not easy to find stocks this low priced with $60 million in total revenues in their history, and $20 million likely this calender year.

In order to boost sales for their traditionally best quarter of the year- CY Q1- Liberator (LUVU) is headed in a new and ideal advertising direction. The self proclaimed “King of All Media” is widely perceived to have invented the “Shock-Jock” genre of radio broadcasting.

Despite his controversial programming, Stern was the unquestioned master of the highly coveted 18-34 male demographic was he broadcast on terrestrial radio. Stern is also credited as a pioneer in the field of syndicating radio content to affiliates around the country.

Since moving to Sirius, Stern’s audience has aged a bit- the 35-64 demographic is more likely to listen to Sirius than the younger group.

However, there can be no argument Stern’s audience is ideal for LUVU products. The sexual wellness revolution’s best spokesperson might be Howard Stern, and his monster demographic will bring a much larger audience to LUVU’s products. Advertising will be heavily concentrated around Valentine’s Day.

Here’s what I’m interested in- will Stern just drive traffic to www.liberator.com? or will Stern mention LUVU’s products can be found at Amazon.com and many main stream stores where their products are found?

I’ll be listening. Look for LUVU to make another leg up next week on this news. Still very undervalued. Ask yourself how many stocks you own in the $.20 to $.25 range delivering $20 million in annual revenues.

LUVU is likely to continue higher this week. I’ve been looking for $.30 plus on this one in the first 1 to 2 months, and I believe we’ll get it if the stock continues to trade this well and the company delivers news like this.

North Springs (NSRS): Use Exterme Caution

January 19, 2012
VolumeXV, Issue 7

Home Page : www.otcjournal.com

Email Questions or Comments To:
editor@otcjournal.com
 

To OTC Journal Members: 

FrogAds (OTC BB: FROG) Leaps To Profits

 

FROG is behaving very well for us today- it broke up to the $.40 level just as I predicted. It’s now up 30% from last week’s alert, and as I mentioned in yesterday’s edition, this surge could be a good profit point for traders- up to you.

Longer term the traffic on the company’s site is growing rapidly, so there could be a lot more upside in this idea. I’ve now provided two great entry levels on this idea- it’s up to you to take advantage of them if you like.

North Springs Resources (OTC BB: NSRS): Use Extreme Caution

 

North Springs- a stock I’ve been following since Dec 27th, is simply too good to be true. I’m kicking myself for not buying some, but I’m sure if I had I would have sold it by now. This has been a red hot penny stock, and I wish I’d covered it back then.

However, if you’re in this one, extreme caution is warranted at this level. First of all, I believe you’d have to be insane to buy this stock at this point. The early promoters have done a marvelous job bringing a huge audience to this story, and the stock has gone berserk.

However, charts like this always have an unhappy ending. I suspect yesterday’s giant bar up was a short squeeze. At some point this stock will turn south, and getting out will be a very crowded trade. I predict you will see the stock lose 70% of its value in one day.

A quick look at the SEC filings can give a little insight into what the company might be worth. As of the last quarterly filing, the company had total assets of $60,000, and $16 in cash. Yes- that’s not $1.6 million- that’s actually $16 total. Not even 20 bucks.

Since the end of October the company has entered into an arrangement to be able to borrow $1 million in cash from a creditor, so they are not penniless. Far more interesting is the market valuation.

At last count, there were 696 million shares I&O. 80 Million of those shares were cancelled on December 29th, leaving a total of 616 million shares I&O. So, based on today’s price of about $.90, the market is placing a value of over $.5 billion on this start up mining company in Nevada that’s never put a drill bit in the ground.

The huge jump Tuesday looks to me like a short squeeze. Market makers who looked at the fundamentals and the promotion probably went short in the early going, but were blown out of their positions and forced to buy.

I’m not saying this stock can’t go higher. I have no idea if it will or it won’t. I’m just saying use extreme caution if you’re looking to buy this stock, or consider taking your profits. When it collapses, all the hot money will be looking for the door, and this sort of crowded trade never goes well for buyers at the top.

It’s known as holding the burning match. The last one holding the burning match gets their fingers burned.

Home Page : www.otcjournal.com

Email Questions or Comments To:

editor@otcjournal.com

 


 

Refer
A Friend

If you find the OTC Journal informative
and profitable, please forward our newsletter alert service to like-minded
friends and associates who share similar market interests.


Ensure
Newsletter Delivery

To ensure newsletter delivery, you
can add any additional email
addresses you may have to the OTC Journal Member List. Receiving the OTC
Journal Newsletter in multiple locations is the best way of making sure
you don’t miss the next investing or trading opportunity! For web based
email addresses, the OTC Journal recommends @yahoo.com or @aol.com for
timely and reliable email newsletter delivery.

Note: Your email address will
be kept strictly confidential, and will not be shared with any other entity
for any purpose at any time. If you no longer wish to receive the OTC Journal,
simply follow the instructions located at the bottom of every OTC Journal
Newsletter Edition.

 


 

 

Disclaimer
DISCLAIMER

The OTC Journal Newsletter is an
electronic publication committed to providing our readers with useful information
on publicly traded companies. The Newsletter contracts with publicly traded
companies and receives compensation from them in the form of cash and sometimes
restricted securities as payment for publishing information and opinion
about the company and the trading market for their securities. Principals
of the Newsletter may also purchase or sell securities of the companies
in the open market from time to time. The positions that the Newsletter
or its principals maintain in securities of the companies are disclosed
here (click
here
) and should be considered in making an investment decision regarding
these companies securities.  The Newsletter may be deemed to have
a conflict of interest between its open market activity and positions in
these securities and the timing of and opinions expressed in its publications
concerning these companies.  The publications should not be considered
to be independent publications concerning the company.

All statements and opinions expressed
herein are those of the editors and are subject to change without notice.
The Newsletter maintains editorial control over its publications and the
companies profiled therein do not have any editorial rights concerning
the information published about them. A profile, description, or other
mention of a company in the newsletter is neither an offer nor solicitation
of an offer to buy or sell any securities mentioned. While we believe all
sources of information provided by us and contained in our publication
to be accurate and reliable, we cannot and do not guarantee the accuracy
of information we received from third parties.

READERS  ARE ENCOURAGED TO DO
THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED IN
THIS PUBLICATION. INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A
HIGH DEGREE OF RISK.

We encourage our readers to invest
carefully and read the investor information available at the web sites
of the Securities and Exchange Commission (“SEC”) at http://www.sec.gov
and/or the National Association of Securities Dealers (“NASD”) at http://www.finra.org.
We also recommend that you read the SEC advisory to investors concerning
Internet Stock Fraud, which can be found at http://www.sec.gov/consumer/cyberfr.htm.
Readers can review all public filings by companies at the SEC’s EDGAR page.
The NASD has published information on how to invest carefully at its web
site.

The information found in this profile
is protected by the copyright laws of the united states and may not be
copied, or reproduced in any way without the expressed, written consent
of the editors of otcjournal.com.

 

You can unsubscribe
from this list at any time by Clicking
Here
. If you are having difficulty removing yourself or wish to change
your address please go to http://www.otcjournal.com/opt/?email=$subst(‘Recip.EmailAddr’).

Two Earnings Suprises: CALL and DXCM

 

January 18, 2012
Volume XV, Issue 7

Home Page : www.otcjournal.com

Email Questions or Comments To:
editor@otcjournal.com
 

To OTC Journal Members: 

Quick Review of 2012

 

I’ve covered two penny stocks so far in 2012. FrogAds (OTC BB: FROG), and Liberator (OTC BB: LUVU).

Here’s a quick update on both situations. I tried to pick a bottom for a bounce in FROG (yes, pun intended), and missed by a couple of days. The stock is bouncing now. We started with this idea back in December, and it was really good to us the first go round. The first entry level was $.41, and the stock ran up to a high of $.58 over the next two trading days.

Over the holidays FROG pulled back in quiet trading, and hit a low of $.25. Last week, I suggested it was ready to rally in the $.30 to $.33 range, but I was off by a couple of days. The stock dropped a bit lower before beginning a serious rebound, which is underway now.

FROG traded big volume yesterday- 1.4 million shares- it’s highest day ever, and today has traded over 500,000 shares already.

Early this week, FROG announced a substantial increase in traffic- Alexa ranks their site 61,228 globally, and 35,300 in the US. Anything under 100,000 is considered top tier. The stock is getting some nice traction on this news, and trading really strong volume.

I hope the stock can find its way back into the $.40 range on this surge. If so, traders might consider taking a profit- investors just hang in there for a while as their traffic grows.

Liberator (OTC BB: LUVU) is trading rather quietly. I introduced the company at $.15, and today the stock is $.20, for a solid short term gain of 28% over a couple of weeks. This stock is still trading rather quietly, but volume has increased nicely over the last couple of days, hitting about the 120,000 share level both days.

While that doesn’t seem like a lot of volume, it’s worth remembering this stock had never traded until it was introduced in the OTC Journal, shortly after which it hit a high of $.225 for a 50% gain in the short term if you jumped in early.

LUVU will have a record Q4 ’11 of $4.2 million, and is nearly certain to be a $20 million plus company in CY 2012. I also expect the company to turn cash flow positive in CY’12. In other news, research firm Goldgaber Research pegged the stock at $1 in the next 12 months, citing “The progress the franchise is becoming a main stream brand.”

If you’d like to read the Goldgaber Research piece, just click here, and off you go.

In summary, FROG is highly volatile and trading a lot of volume- LUVU is not as volatile and starting to catch the attention of investors. IF FROG surges 20% to 30%, you might consider taking a trading profit. LUVU is at a good level to hold or open a new position.

Two Earnings Trades

 

I’ve been reaching out to my vast network of contacts in the small stock world, and believe I have two candidates that will deliver big earnings upside surprises when they release their Q4 and full year audited numbers. Since this publication is committed to low priced stocks, I’ll show you how to make a lot of money if you pledge just a little capital.

The two names are Dexcom (NASDAQ: DXCM) and Magic Jack (NASDAQ: CALL).

Magic Jack (NASDAQ: CALL) is the company that advertises incessantly about its $17 annual fee for your phone service. Sources who reported to me after the recent Consumer Electronics Show in Las Vegas last year inform me that a recent technology change is allowing the Magic Jack solution to function extremely well, and adoption is consumers are not adopting the product far more rapidly than in the past.

As you can see from the chart, the stock is already starting to price in a big change. The stock recently split 2 for 1, and investors generally expect splits to lead to higher prices. Analysts are estimating the company will earn $1.01 in 2012, up from EPS of $.07 in 2011.

I haven’t been able to find out when CALL will release it’s audited 2011 year end numbers. The company legally has until March 15. However, I would expect it to be sometime in February.

I believe CALL is going to beat estimates quite handily, and there’s a lot of upside in this one from current levels.

Dexcom (NASDAQ: DXCM) is a stock I’ve followed since it’s IPO in 2005. I ecommended this stock in 2005 out in front of the company’s first FDA approval. The stock went from my original entry level of $16 to $26 on that trade. I recommended selling the stock at $24, and made $50,000 on that trade myself.

DXCM is a medical device company focusing on the diabetes market- specifically the difficult to treat Type 1 version- at this time. FDA Approvals will be sought for other versions as well. In the past couple of years sales have improved markedly as the company was able to get an insurance code which allows for insurance coverage of their device.

DXCM has developed a small sensor which is implanted into a patient’s abdomen- it’s not much more invasive than an injection. The sensor provides real time blood glucose data to a device that is about the size of a cell phone. The patient can monitor their blood chemistry in real time, and administer the proper amount of medication to keep their blood glucose levels in the normal range as needed.

Analysts are underestimating the rapid growth at the company as diabetes is reaching nearly epidemic proportions on a global basis. I expect the company to turn in far better numbers than the street expects.

Yahoo’s earning calender has DXCM announcing on Feb 29th. Analyst are expecting a loss of $.17 per share.

When trading on anticipated earnings surprises to the upside, it’s important to recognize the stock is likely to trade up into the earnings report, surge at the open, and then retreat swiftly as sellers who were betting on the numbers lock in their gains.

Since this is primarily a penny stock newsletter, let’s look at how we might be able to make a lot of money with a little capital. If you want to bet on the year end earnings releases for both of these stocks, your best bet for a little money is using options.

To go long, you can either buy call options, or go short the puts. With options, you always want to be a seller if possible. However, if you go short the puts, the most you can make on the trade is the amount of money you have at risk. You hope the put goes to zero, and you double your investment.

Going long the calls provides more upside, but you’ll generally pay a higher premium.

In the case of CALL, I would recommend:

  • The March $15 calls which you can buy at $1.40. if you buy 10 calls, it runs $1400, and it represents the right to buy 1,000 shares.
  • For a greater risk/reward, go to the March $17.50 calls at $.50. $500 gets you the right to buy 1,000 shares at $1.7.50.

In the case of DXCM, I would recommend:

  • The March $10 calls which you can buy at $1.40 as well. If you use a limit order, you might be able to get them cheaper. Again, a $1400 investment in 10 calls controls 1,000 shares at $10.
  • For a greater risk reward scenario, the $12.50 March calls are only $.45. That might be the way to go. $450 controls 1,000 shares at $12.50. With the stock at $10.50 that might seem a little silly, but if the stock ends up at $15, you’ll be ringing the cash register.

There’s a couple of earnings trades for you for the upcoming earnings releases, and a way to pledge a little money to either make a lot, or lose a little. Be ready to sell these ideas on the days their year end earnings are released. With both stocks in strong uptrends, you should lock in now if you like these ideas.

More soon.

Home Page : www.otcjournal.com

Email Questions or Comments To:

editor@otcjournal.com

 


 

Refer
A Friend

If you find the OTC Journal informative
and profitable, please forward our newsletter alert service to like-minded
friends and associates who share similar market interests.


Ensure
Newsletter Delivery

To ensure newsletter delivery, you
can add any additional email
addresses you may have to the OTC Journal Member List. Receiving the OTC
Journal Newsletter in multiple locations is the best way of making sure
you don’t miss the next investing or trading opportunity! For web based
email addresses, the OTC Journal recommends @yahoo.com or @aol.com for
timely and reliable email newsletter delivery.

Note: Your email address will
be kept strictly confidential, and will not be shared with any other entity
for any purpose at any time. If you no longer wish to receive the OTC Journal,
simply follow the instructions located at the bottom of every OTC Journal
Newsletter Edition.

 


 

 

Disclaimer
DISCLAIMER

The OTC Journal Newsletter is an
electronic publication committed to providing our readers with useful information
on publicly traded companies. The Newsletter contracts with publicly traded
companies and receives compensation from them in the form of cash and sometimes
restricted securities as payment for publishing information and opinion
about the company and the trading market for their securities. Principals
of the Newsletter may also purchase or sell securities of the companies
in the open market from time to time. The positions that the Newsletter
or its principals maintain in securities of the companies are disclosed
here (click
here
) and should be considered in making an investment decision regarding
these companies securities.  The Newsletter may be deemed to have
a conflict of interest between its open market activity and positions in
these securities and the timing of and opinions expressed in its publications
concerning these companies.  The publications should not be considered
to be independent publications concerning the company.

All statements and opinions expressed
herein are those of the editors and are subject to change without notice.
The Newsletter maintains editorial control over its publications and the
companies profiled therein do not have any editorial rights concerning
the information published about them. A profile, description, or other
mention of a company in the newsletter is neither an offer nor solicitation
of an offer to buy or sell any securities mentioned. While we believe all
sources of information provided by us and contained in our publication
to be accurate and reliable, we cannot and do not guarantee the accuracy
of information we received from third parties.

MarketByte LLC has been pledged fees totalling $18,000 for coverage of Frogads by Lake Media Group.MarketByte LLC has been paid a fee of $15,000 for coverge of Liberator, Inc by the company. Larry Isen, the editor and publisher of the OTC Journal, owns 88,000 shaers of LUVU purchased in a private placement at $.25 per share.

READERS  ARE ENCOURAGED TO DO
THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED IN
THIS PUBLICATION. INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A
HIGH DEGREE OF RISK.

We encourage our readers to invest
carefully and read the investor information available at the web sites
of the Securities and Exchange Commission (“SEC”) at http://www.sec.gov
and/or the National Association of Securities Dealers (“NASD”) at http://www.finra.org.
We also recommend that you read the SEC advisory to investors concerning
Internet Stock Fraud, which can be found at http://www.sec.gov/consumer/cyberfr.htm.
Readers can review all public filings by companies at the SEC’s EDGAR page.
The NASD has published information on how to invest carefully at its web
site.

The information found in this profile
is protected by the copyright laws of the united states and may not be
copied, or reproduced in any way without the expressed, written consent
of the editors of otcjournal.com.

 

You can unsubscribe
from this list at any time by Clicking
Here
. If you are having difficulty removing yourself or wish to change
your address please go to http://www.otcjournal.com/opt/?email=$subst(‘Recip.EmailAddr’).

FROG Finding Its Legs

 

 

January 11, 2012
Volume XV, Issue 6

Home Page : www.otcjournal.com

Email Questions or Comments To:
editor@otcjournal.com
 

To OTC Journal Members: 

Froggy’s Jumping Back Up

 

Nice win in the short term from last year. I believe I’ll just call this one the FROGGIE. Very catchy. This site could absolutely explode. Us older internet users- those of us who have been there from the beginning- we have watched the unopposed development of Craigslist.

This plain vanilla web site of global personal ads has grown from one man’s innocent hobby to 20 billion page views per month- all uncontested with little or no competition.

Wake up Craig- there’s a new amphibian on the block. FrogAds is trying to muscle into Craiglist territories, and meeting with some early success on the advertiser end.

I wrote about this company back on December 13th. The stock leapfrogged from $.42 to $.60 in a couple of trading days, and starting drifting back down through the Christmas and New Years holidays.

FROG started jumping back up yesterday and traded nearly 500,000 shares, making it appear as if FROGGIE is getting ready to leap off the lily pad.

Of late, FROG has announced very shortly after its official commercial launch, www.frogads.com has moved into the top 65,000 most trafficked web sites and now has 1.5 million ads placed on the site.

Frogads will also be the first major site to combine classified ads with traditional online advertising and auction sales. This is unique- no one has put these services combined together- until now.

FROG Finding Its Legs

 

FROG jumped back into the picture after a rather protracted pullback of late, and might be starting a nice rebound phase.

As you can see from the chart, both the price and volume are on the increase.

The stock traded down as low as $.22 early in the year. I’ve been watching for a sign of a rebound in this one.

It happened yesterday when the stock traded very high volume- nearly 1/2 million shares, and closed very near the high of its range for the day.

It seems to me this stock is entitled to bounce back into the at least the $.42 range- that would be 61.8% of the drop.

Longer term this one might get interesting. Making the top 100,000 most trafficked web sites in such a short period of time is quite an achievement.

If the site becomes viral, look out above. This one could really get some legs. A good entry level today is about yesterday’s closing level- around $.33.

If this stock is ready to deliver a nice technical rebound, there’s a great trade here.

Home Page : www.otcjournal.com

Email Questions or Comments To:

editor@otcjournal.com

 


 

Refer
A Friend

If you find the OTC Journal informative
and profitable, please forward our newsletter alert service to like-minded
friends and associates who share similar market interests.


Ensure
Newsletter Delivery

To ensure newsletter delivery, you
can add any additional email
addresses you may have to the OTC Journal Member List. Receiving the OTC
Journal Newsletter in multiple locations is the best way of making sure
you don’t miss the next investing or trading opportunity! For web based
email addresses, the OTC Journal recommends @yahoo.com or @aol.com for
timely and reliable email newsletter delivery.

Note: Your email address will
be kept strictly confidential, and will not be shared with any other entity
for any purpose at any time. If you no longer wish to receive the OTC Journal,
simply follow the instructions located at the bottom of every OTC Journal
Newsletter Edition.

 


 

 

Disclaimer
DISCLAIMER

The OTC Journal Newsletter is an
electronic publication committed to providing our readers with useful information
on publicly traded companies. The Newsletter contracts with publicly traded
companies and receives compensation from them in the form of cash and sometimes
restricted securities as payment for publishing information and opinion
about the company and the trading market for their securities. Principals
of the Newsletter may also purchase or sell securities of the companies
in the open market from time to time. The positions that the Newsletter
or its principals maintain in securities of the companies are disclosed
here (click
here
) and should be considered in making an investment decision regarding
these companies securities.  The Newsletter may be deemed to have
a conflict of interest between its open market activity and positions in
these securities and the timing of and opinions expressed in its publications
concerning these companies.  The publications should not be considered
to be independent publications concerning the company.

All statements and opinions expressed
herein are those of the editors and are subject to change without notice.
The Newsletter maintains editorial control over its publications and the
companies profiled therein do not have any editorial rights concerning
the information published about them. A profile, description, or other
mention of a company in the newsletter is neither an offer nor solicitation
of an offer to buy or sell any securities mentioned. While we believe all
sources of information provided by us and contained in our publication
to be accurate and reliable, we cannot and do not guarantee the accuracy
of information we received from third parties. MarketByte LLC has been pledged fees totalling $18,000 for coverage of Frogads by Lake Media Group.

READERS  ARE ENCOURAGED TO DO
THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED IN
THIS PUBLICATION. INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A
HIGH DEGREE OF RISK.

We encourage our readers to invest
carefully and read the investor information available at the web sites
of the Securities and Exchange Commission (“SEC”) at http://www.sec.gov
and/or the National Association of Securities Dealers (“NASD”) at http://www.finra.org.
We also recommend that you read the SEC advisory to investors concerning
Internet Stock Fraud, which can be found at http://www.sec.gov/consumer/cyberfr.htm.
Readers can review all public filings by companies at the SEC’s EDGAR page.
The NASD has published information on how to invest carefully at its web
site.

The information found in this profile
is protected by the copyright laws of the united states and may not be
copied, or reproduced in any way without the expressed, written consent
of the editors of otcjournal.com.

 

You can unsubscribe
from this list at any time by Clicking
Here
. If you are having difficulty removing yourself or wish to change
your address please go to http://www.otcjournal.com/opt/?email=$subst(‘Recip.EmailAddr’).

Meet The Fockers Meets LUVU

 

 

 

January 8, 2012
Volume XV, Issue 4

Home Page : www.otcjournal.com
Email Questions or Comments To:
editor@otcjournal.com

To OTC Journal Members: 

Meet The Fockers Meets LUVU

 

Meet The Fockers is the 2004 comedic comic film starring Ben Stiller, Teri Polo, Dustin Hoffman, and Barbara Streisand. Greg Focker (Stiller’s character) is marrying Pam Byrnes (Polo’s Character). Her retired CIA agent dad (De Niro) wants to meet his quirky, hippy like parents- Hoffman and Streisand.

It was the second movie in the franchise, and was wildly popular. The film cost $80 million to make, and ended up grossing over $500 million worldwide.

Roz Focker – Greg’s mother (played by Barbara Streisand), plays a sex therapist who specializes in senior sexuality. The plot line is hysterical, especially when Streisand interacts with uptight, ex CIA agent Robert Di Niro.

There’s plenty of sexual over tones in the movie, especially in light of Streisand’s character.

One of the unintended stars of the movie is some unique furniture displayed prominently in several of the scenes. This same furniture has been shown in several other Hollywood movies, and more recently on a highly popular reality show.

Atlanta based Liberator, Inc (LUVU), a company that has generated over $60 million in revenues since its inception in 2002, came up with a very clever way to use left over foam scraps. The company is hitting new sales records every quarter, and is just starting to turn profitable for the first time in its history.

Liberator takes left over foam and cuts it into a variety of triangle and incline shapes to create specially shaped pillows and furniture. It’s primarily designed as bedroom accessories, but they make lines of bean bag chairs popular with college students and others.

While it doesn’t get a lot of attention, there is a whole new category of consumer products being categorized as Sexual Wellness or Sexual Well Being.

Visit the Web Site at www.soap.com. It’s a household and personal care site selling everything from discount diapers to toothpaste and hair products. There’s a category on the home page on the top menu bar for Sexual Wellness.

These products are getting main stream adoption rapidly. Liberator’s single biggest customer is Amazon.com. Amazon has a full product offering in a section known as “Sexual Wellness”. Click Here to visit Amazon’s product offerings in this category.

Drugstore.com, Vitaminshop.com, and Brookline are other retailers moving rapidly into the space. These products are no longer shopped for a seedy little specialty stores. It’s all behind closed doors, but it’s main stream now, and the market for these products is growing very rapidly.

Liberator (OTC BB: LUVU) Delivering the Numbers

 

This past September, LUVU delivered its best quarter ever. The companies top line came in at $5.6 million- a 113% increase from the same quarter in 2010. Gross profits were $1.8 million, and the company’s adjusted EBITDA loss was about $5,000. This company is on the verge of making the turn to profitability, which can be one of the best times to own the stock-especially when its extremely cheap.

Friday, after the market closed, LUVU issued guidance for the FYQ2- the December quarter. The company announced projected revenues of $4.2 million, which will be a 14% increase over the same quarter in 2011. The top line is down a bit from the September quarter, but the company sold an online division for $800,000 during the quarter which didn’t work with their future growth plans, leaving some extra cash on their balance sheet.

According to Business Week, the commercial sex industry is now ranked one of the “Top 5 Rising Industries for 2031″- expected to grow over 17% each ear. In 2006, this industry contributed $13.3 billion to the total US economy. It’s bigger than the NFL, NBA, and MLB combined.

At its current growth rate, is will be a $47 billion global industry by 2030. There are numerous research reports highlighted how the commercial sex industry has moved from underground, small scale operations to more normalized, main streamed companies.

For more information, read researcher Emily Empel’s on The Future of the Commercial Sex Industry in 2030. Click on the title to get there.

Conclusion- Your Upside

 

Lest you think there’s no money to be made in the few stocks in this sector, think again. Check out this chart.

This is Rick’s Cabaret. Yes- this was a reverse merger bulletin board stock many year’s ago. This $84 million per year company is been a smokin hot stock from time to time. As you can see from this weekly chart, RICK was $4 in 2009, and nearly $30 in 2010. Not bad if you owned it at $4.

LUVU is a story of clever American ingenuity. I love stories like this. Found Lewis Friedman took discarded foam scraps and turned them into $60 million in revenues over 9 years.

Furthermore, in the Sexual Wellness category, LUVU is the only company that exists with a real brand. With customers like Amazon, Drugstore.com, Wallgreens, and VitaminShop.com, their products are easily attainable by Main Stream consumers.

Absolutely no one knows about this stock. I personally invested in the company about 3 years ago in a private placement priced at $.25 per share. The company was smaller than, but market valuations were richer. I had 100,000 shares- I now have nearly 90,00 shares left.

As you can see from this chart, LUVU has traded sporadically throughout 2011, but has traded up as high at $.30- double Friday’s closing price. Funds were raised for this company at $.25, so open market buyers will enjoy 66% profits before myself and the other investors break even.

I suspect this one will trade up rather easily and rapidly once investors start catching on to the growth in both their sector and their company.

There’s under 90 million shares I&O, so at $.15 the entire market cap $13.5 million-it’s trading about 1/2 of annual sales, which is absurdly cheap.

I see no reason why this stock couldn’t trade into the $.30 to $.45 range over the next 30 to 45 days as more investor get exposed to the story. From Friday’s close, this would represent 100% to 150% return on investment.

If you like this idea, I would act right at the open tomorrow, and of course use a limit order- I wouldn’t pick it up any higher than $.18 to $.20 on the first day.

However, I do plan to cover every development out of this company for the next 30 days, or longer. Use $.12 as your SSL. Risk 3 cents to double your money or more.

Here’s one last item. This company was recently featured on the Bravo Show the Real Housewifes of Atlanta. They make a visit to the Liberator retail store. WWW.Liberator.com is their retail web site.

Click Here to check it the Real Houswives of Atlanta show. Of course, I had never watched the show, but I have to admit this is pretty entertaining. This is the kind of publicity that makes shareholders a lot of money.

Home Page : www.otcjournal.com

Email Questions or Comments To:

editor@otcjournal.com

 


 

Refer
A Friend

If you find the OTC Journal informative
and profitable, please forward our newsletter alert service to like-minded
friends and associates who share similar market interests.


Ensure
Newsletter Delivery

To ensure newsletter delivery, you
can add any additional email
addresses you may have to the OTC Journal Member List. Receiving the OTC
Journal Newsletter in multiple locations is the best way of making sure
you don’t miss the next investing or trading opportunity! For web based
email addresses, the OTC Journal recommends @yahoo.com or @aol.com for
timely and reliable email newsletter delivery.

Note: Your email address will
be kept strictly confidential, and will not be shared with any other entity
for any purpose at any time. If you no longer wish to receive the OTC Journal,
simply follow the instructions located at the bottom of every OTC Journal
Newsletter Edition.

 


 

 

Disclaimer
DISCLAIMER

The OTC Journal Newsletter is an
electronic publication committed to providing our readers with useful information
on publicly traded companies. The Newsletter contracts with publicly traded
companies and receives compensation from them in the form of cash and sometimes
restricted securities as payment for publishing information and opinion
about the company and the trading market for their securities. Principals
of the Newsletter may also purchase or sell securities of the companies
in the open market from time to time. The positions that the Newsletter
or its principals maintain in securities of the companies are disclosed
here (click
here
) and should be considered in making an investment decision regarding
these companies securities.  The Newsletter may be deemed to have
a conflict of interest between its open market activity and positions in
these securities and the timing of and opinions expressed in its publications
concerning these companies.  The publications should not be considered
to be independent publications concerning the company.

All statements and opinions expressed
herein are those of the editors and are subject to change without notice.
The Newsletter maintains editorial control over its publications and the
companies profiled therein do not have any editorial rights concerning
the information published about them. A profile, description, or other
mention of a company in the newsletter is neither an offer nor solicitation
of an offer to buy or sell any securities mentioned. While we believe all
sources of information provided by us and contained in our publication
to be accurate and reliable, we cannot and do not guarantee the accuracy
of information we received from third parties. MarketByte LLC has been paid a fee of $15,000 for coverge of Liberator, Inc by the company. Larry Isen, the editor and publisher of the OTC Journal, owns 88,000 shaers of LUVU purchased in a private placement at $.25 per share.

READERS  ARE ENCOURAGED TO DO
THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED IN
THIS PUBLICATION. INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A
HIGH DEGREE OF RISK.

We encourage our readers to invest
carefully and read the investor information available at the web sites
of the Securities and Exchange Commission (“SEC”) at http://www.sec.gov
and/or the National Association of Securities Dealers (“NASD”) at http://www.finra.org.
We also recommend that you read the SEC advisory to investors concerning
Internet Stock Fraud, which can be found at http://www.sec.gov/consumer/cyberfr.htm.
Readers can review all public filings by companies at the SEC’s EDGAR page.
The NASD has published information on how to invest carefully at its web
site.

The information found in this profile
is protected by the copyright laws of the united states and may not be
copied, or reproduced in any way without the expressed, written consent
of the editors of otcjournal.com.

 

You can unsubscribe
from this list at any time by Clicking
Here
. If you are having difficulty removing yourself or wish to change
your address please go to http://www.otcjournal.com/opt/?email=$subst(‘Recip.EmailAddr’).

My Webinar on Fraud; Coming Attraction

January 7, 2012
Volume XV, Issue 2

Home Page : www.otcjournal.com

Email Questions or Comments To:
editor@otcjournal.com
 

To OTC Journal Members: 

Some Of My Best Work- A Webinar For You

 

As many of you know, the OTC Journal is only one of my publications. This is the beginning of my 14th year with the OTC Journal. As 2011 wasn’t a good year in the markets, I expect 2012 to be far better.

My other newsletter, which is now going into its second year of publication, is focused on Emerging China Stocks. You can check out the web site at www.emergingchinastocks.com. Those of you who follow the sector know it was a complete bloodbath in 2011. The allegations of fraud, many of which turned out to be true, completely destroyed a sector of about 600 publicly traded companies, most of whom are perfectly legitimate.

One of the greatest fund managers of all time- Anthony Bolton, who manages the Fidelity China Special Situations fund, described 2011 as “BRUTAL” for investors.

Bolton, who has averaged 20% a year for the last 20 years in his UK Special Situations fund, believes the world’s investment community will look for growth again soon, and they’ll find it in China equities.

Bolton is continuing to accumulate China Small Caps in the $.5 billion fund, but he is focusing primarily on companies with good corporate governance policies.

I lost a substantial amount of my own personal capital in the 2011 China disasters, but I’ve learned a lot. Rather than fold my tent and disappear into the desert night, I have learned after 23 years in the small cap world that there’s opportunity in crisis.

Here’s where this is all leading. In the second half of 2011 I spent a lot of time educating myself and learning how China companies commit fraud. For investors on the long side, the China small cap companies who are publishing accurate numbers represent the values of a lifetime.

There’s 600 China small caps- 200 trading with senior US listings. About 25 have been credibly demonstrated to be committing fraud, and I believe there will be a few more.

So, the key to making money in these beaten down stocks is the ability to identify which are committing fraud to a material extent, and which are not.

I’ve written a produced an 8 Part video WEBINAR on “How China Companies Commit Fraud”. It’s free- no strings attached, and the first opportunity to attend will be next Thursday.

Lest you think these stocks haven’t hit bottom, let me point out 3 of my core ideas in EmergingChinaStocks are up 140%, 75%, and 62% respectively off the October lows.

If you’d like to attend the WEBINAR, Click Here, go to the following sign up page:

http://bit.ly/PowerOfEight

Tomorrow’s New Idea

 

Tomorrow I’ll be introducing my first new penny stock trading idea for 2012.

This is a $.15 stock that no one is following and no one knows about. However, this is no start up. The company is coming off its best quarter ever. In September, this company delivered $5.6 million in quarterly revenues with 30% margins and an extremely small paper loss. The company was very nearly cash flow positive for the first time in its history. I invested privately in this company about 3 years ago at $.25, and I still hold 85% of the shares. Since the company is performing better than it ever has, you’re getting a far better entry level than I had.

This company is riding a 21st Century wave being adopted rapidly into Main Stream society. It’s a bit unusual, and promises to be very profitable. They manufacture and distribute a line of products in a specific category, and their largest customers are the likes of:

  • Amazon
  • Brookstone
  • Drugstore.com
  • Overstock
  • Walgreens

Their products are getting national recognition having recently been featured in a number of top run Hollywood Movies and one highly rated cable reality show.

Got your attention? I’m working on the initial presentation now. I plan to publish several editions on this one over the course of the next month. Tomorrow is your OTC Journal “First Look”.

Stand by to be entertained.

Home Page : www.otcjournal.com

Email Questions or Comments To:

editor@otcjournal.com

 


 

Refer
A Friend

If you find the OTC Journal informative
and profitable, please forward our newsletter alert service to like-minded
friends and associates who share similar market interests.


Ensure
Newsletter Delivery

To ensure newsletter delivery, you
can add any additional email
addresses you may have to the OTC Journal Member List. Receiving the OTC
Journal Newsletter in multiple locations is the best way of making sure
you don’t miss the next investing or trading opportunity! For web based
email addresses, the OTC Journal recommends @yahoo.com or @aol.com for
timely and reliable email newsletter delivery.

Note: Your email address will
be kept strictly confidential, and will not be shared with any other entity
for any purpose at any time. If you no longer wish to receive the OTC Journal,
simply follow the instructions located at the bottom of every OTC Journal
Newsletter Edition.

 


 

 

Disclaimer
DISCLAIMER

The OTC Journal Newsletter is an
electronic publication committed to providing our readers with useful information
on publicly traded companies. The Newsletter contracts with publicly traded
companies and receives compensation from them in the form of cash and sometimes
restricted securities as payment for publishing information and opinion
about the company and the trading market for their securities. Principals
of the Newsletter may also purchase or sell securities of the companies
in the open market from time to time. The positions that the Newsletter
or its principals maintain in securities of the companies are disclosed
here (click
here
) and should be considered in making an investment decision regarding
these companies securities.  The Newsletter may be deemed to have
a conflict of interest between its open market activity and positions in
these securities and the timing of and opinions expressed in its publications
concerning these companies.  The publications should not be considered
to be independent publications concerning the company.

All statements and opinions expressed
herein are those of the editors and are subject to change without notice.
The Newsletter maintains editorial control over its publications and the
companies profiled therein do not have any editorial rights concerning
the information published about them. A profile, description, or other
mention of a company in the newsletter is neither an offer nor solicitation
of an offer to buy or sell any securities mentioned. While we believe all
sources of information provided by us and contained in our publication
to be accurate and reliable, we cannot and do not guarantee the accuracy
of information we received from third parties.

READERS  ARE ENCOURAGED TO DO
THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED IN
THIS PUBLICATION. INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A
HIGH DEGREE OF RISK.

We encourage our readers to invest
carefully and read the investor information available at the web sites
of the Securities and Exchange Commission (“SEC”) at http://www.sec.gov
and/or the National Association of Securities Dealers (“NASD”) at http://www.finra.org.
We also recommend that you read the SEC advisory to investors concerning
Internet Stock Fraud, which can be found at http://www.sec.gov/consumer/cyberfr.htm.
Readers can review all public filings by companies at the SEC’s EDGAR page.
The NASD has published information on how to invest carefully at its web
site.

The information found in this profile
is protected by the copyright laws of the united states and may not be
copied, or reproduced in any way without the expressed, written consent
of the editors of otcjournal.com.

 

You can unsubscribe
from this list at any time by Clicking
Here
. If you are having difficulty removing yourself or wish to change
your address please go to http://www.otcjournal.com/opt/?email=$subst(‘Recip.EmailAddr’).

Welcome to the 14th Year of Penny Stock Coverage

January 5, 2012
Volume XV, Issue 1

Home Page : www.otcjournal.com

Email Questions or Comments To:
editor@otcjournal.com
 

To OTC Journal Members: 

Welcome to the 14th Year of Continuing Coverage

 

You’re probably not going to believe this, but today’s edition is the first of of my 14th year of continuously publishing the OTC Journal. Yes folks, when I started this, I had hair and enthusiasm for the penny stock sector. The OTC Journal is the oldest online penny stock publication in existance.

Today, I still have my enthusiasm for the penny stock market- the hair? Well, as you can see, not so much.

Over the 14 years I’ve been writing the OTC Journal, I’ve seen a lot of change in the penny stock market. Over the last few years it’s not for the better in my view. Thanks to the internet, the OTC world has changed considerably.

The time frames to trade in and out of penny stocks in today’s market environment can be as short as hours or minutes. There’s hundreds of companies looking for exposure, and the information disseminators like myself have ideas coming at us on a nearly daily basis.

The crowd swings from one idea to the next sometimes 3 times a week because the information can get out so rapidly.

This environment can be tough if you’re not glued to your screen and super active. I much prefer an environment where one can take a position in a stock and watch for slow appreciation over a month or two as the company delivers solid fundamental events and growth, and the audience for the stock expands. These are the quality penny stocks- the ones with lots of upside potential and real growth.

Here’s a peak into the future- I’ve already identified four situations I like that I’ll be covering for at least a month. Instead of “here and gone” stories, you’ll get some real follow up and the ideas will have some time to develop. I expect to introduce all of them between now and the end of March.

Some notables over the years: Big winners included Spicy Pickle (SPKL)- $.50 to $2.00 with total liquidity in the Fall of 2007. That one was particularly satisfying for me as I personally invested in the company before it came public and made net profits of over $700,000 for taking the risk. Unfortunately, the 2008 recession killed the company’s growth prospects, and it’s struggling today.

Force Protection (NASDAQ: FRPT) was my second biggest win of all time. We started with that one around $2, and it eventually hit a high of about $26 as I recall. The company was bought out by General Dynamics this past December, so we can’t look at the chart anymore. That one took nearly 2 years to make its high from the first time I wrote about it.

The biggest win of all time was a company called NetSol International (NASDAQ: NTWK). I first covered it at about $1.80 in 1998. At the top of the dot-com craze in March of 2000, the stock hit $75 in one of the greatest short squeezes of all time. This Pakistani software developer is still around, but not flourishing as they once did.

Of course as is the nature of the penny market, the losers are too numerous to review. I really wouldn’t characterize many of the ideas so much as losers. In the small cap world and penny market, you are going to have losers. That’s the nature of the beast. I’d say I it was more the disappointments that have been difficult- every now and then you come across one of these companies that just looks like it can’t miss. Then, somehow, the management team screws it up, and down it goes. Those are my biggest regrets.

I’m going to try to focus on a little longer term coverages going into 2012 so you have a better chance to make more money without worrying minute to minute.

Here’s a look back to the first edition ever published in the OTC Journal. It was May 8, 1998. The company was San Diego based Ontro, inc. I wrote a preview on an upcoming IPO, and gave the information on where to call to get a prospectus and ask for an allocation of the IPO.

Ontro had developed a revolutionary new product called an “Integrated Thermal Container”. It was specialized beverage packaging- you basically popped the top, and the beverage became either hot or cold in a matter of seconds. It was used for things like soup, and was ideal for soldiers in the field, campers, etc.

I can’t remember what happened with the company. But if you want to stroll down memory lane, Click Here to read my first edition.

Coming Attraction

 

My first idea of 2012 will be out on Sunday morning. We’ve had some great success with the Sunday releases, and I hope this will set the stage for a fantastic and highly profitable 2012.

Here’s a little preview:

  • Can you tell me what industry is set to grow from $13.3 billion in 2006 to $46.9 billion in 2030?
  • Can you show me a company in this industry group that achieved $5.6 million in revs in Sept quarter of ’11- up 113% from the same quarter in ’10?
  • Can you show me a company like this, but it only trades at $.15 per share, and no one is following it- yet?

I’ve got it for you, and you’ll be able to read about on Sunday for Monday trading. I think this is an easy double from the current level.

More before Sunday.

Home Page : www.otcjournal.com

Email Questions or Comments To:

editor@otcjournal.com

 


 

Refer
A Friend

If you find the OTC Journal informative
and profitable, please forward our newsletter alert service to like-minded
friends and associates who share similar market interests.


Ensure
Newsletter Delivery

To ensure newsletter delivery, you
can add any additional email
addresses you may have to the OTC Journal Member List. Receiving the OTC
Journal Newsletter in multiple locations is the best way of making sure
you don’t miss the next investing or trading opportunity! For web based
email addresses, the OTC Journal recommends @yahoo.com or @aol.com for
timely and reliable email newsletter delivery.

Note: Your email address will
be kept strictly confidential, and will not be shared with any other entity
for any purpose at any time. If you no longer wish to receive the OTC Journal,
simply follow the instructions located at the bottom of every OTC Journal
Newsletter Edition.

 


 

 

Disclaimer
DISCLAIMER

The OTC Journal Newsletter is an
electronic publication committed to providing our readers with useful information
on publicly traded companies. The Newsletter contracts with publicly traded
companies and receives compensation from them in the form of cash and sometimes
restricted securities as payment for publishing information and opinion
about the company and the trading market for their securities. Principals
of the Newsletter may also purchase or sell securities of the companies
in the open market from time to time. The positions that the Newsletter
or its principals maintain in securities of the companies are disclosed
here (click
here
) and should be considered in making an investment decision regarding
these companies securities.  The Newsletter may be deemed to have
a conflict of interest between its open market activity and positions in
these securities and the timing of and opinions expressed in its publications
concerning these companies.  The publications should not be considered
to be independent publications concerning the company.

All statements and opinions expressed
herein are those of the editors and are subject to change without notice.
The Newsletter maintains editorial control over its publications and the
companies profiled therein do not have any editorial rights concerning
the information published about them. A profile, description, or other
mention of a company in the newsletter is neither an offer nor solicitation
of an offer to buy or sell any securities mentioned. While we believe all
sources of information provided by us and contained in our publication
to be accurate and reliable, we cannot and do not guarantee the accuracy
of information we received from third parties.

READERS  ARE ENCOURAGED TO DO
THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED IN
THIS PUBLICATION. INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A
HIGH DEGREE OF RISK.

We encourage our readers to invest
carefully and read the investor information available at the web sites
of the Securities and Exchange Commission (“SEC”) at http://www.sec.gov
and/or the National Association of Securities Dealers (“NASD”) at http://www.finra.org.
We also recommend that you read the SEC advisory to investors concerning
Internet Stock Fraud, which can be found at http://www.sec.gov/consumer/cyberfr.htm.
Readers can review all public filings by companies at the SEC’s EDGAR page.
The NASD has published information on how to invest carefully at its web
site.

The information found in this profile
is protected by the copyright laws of the united states and may not be
copied, or reproduced in any way without the expressed, written consent
of the editors of otcjournal.com.

 

You can unsubscribe
from this list at any time by Clicking
Here
. If you are having difficulty removing yourself or wish to change
your address please go to http://www.otcjournal.com/opt/?email=$subst(‘Recip.EmailAddr’).

FrogAds (FROG): Leap Frogging To Success

 

January 13, 2011
Volume XIII, Issue 4

Home Page : www.otcjournal.comEmail Questions or Comments To:
editor@otcjournal.com

To OTC Journal Members: 

Turning Nothing Into Billions

 

The internet is a crazy world of unexpected success. Some of us older dogs like to reminisce about the Apple story- Steve Jobs and Steve Wozniak creating the personal computer in a garage. It makes for a great investment story.

However, there’s a lot more Apple like stories in the internet than in any other industry. eBay- started on a PC. Facebook- in a dorm room. Amazon- a bookseller in Washington. How about recent dubiously priced IPO Groupon (NASDAQ: GRPN)- it started in an office building in Chicago by offering a discount on a pizza to a small email list- it went on to become the fastest company in history to $1 billion in sales.

Then there’s Craigslist. Craigslist is a very plain looking web site containing classified ads from cities all over the world. It was started in 1995 by San Francisco resident Craig Newmark- a relative newcomer to the area looking to spread the word on social events to software and internet developers in the Bay Area.

Craigslist became so huge that founder Newmark had to start charging for classified services in 2004 to help defray bandwidth and programming costs. Job posting advertisers were required to pay $25 to place a job posting in NY or LA.

Today, Craigslist sports over 20 billion page views per month- making it the 37th most heavily trafficked site in the world, and 10th in the United States according to tracking service Alexa.

The paid job ads have expanded to other cities and cost $75. As a private company, Craigslist does not disclose anything about its financial condition. However, analysts have estimated the company might have generated as much as $150 million in 2007. eBay is believed to own 25% of the company.

The layout of the home page has not changed in any significant way since its inception in 1996. Founder Craig Newmark believes the simplicity keeps people coming back. Despite many offers, Newman has refused to run ad banners for all these years.

With the traffic the site garners, analysts believe it would be worth over $1 billion in a sale.

Leap Frogging To Success: FrogAds.com (OTC BB: FROG)

 

It’s ranked #65,000 in the world as of today before they’ve even started marketing. Anything in the top 100,000 is considered very strong, so at this early stage getting to number 65,000 is quite a feat. By the time it’s ranked 30,000, you’ll have made a killing in the stock.

FrogAds.com recently launched a Craigslist style service. I suggest you check out the site and cruise around a bit. WWW.Frogads.com will get you there.

Their model is going to differ from Craigslist, but far more profitable as it starts to get traction and the audience increases in size. Here’s how their model works.

Classified ads on Craigslist are all free. Job posters pay a fee for use.

FrogAds.com is going to allow for paying advertisers to “laser target” their consumers. FROG will allow and ad insert for every 10 classified ads. Advertorials will be specific to the section of the site. So, if you’re trying to sell a car, you can put your ad where consumers are looking at cars. This will apply to any product.

PPC (pay per click) and Page Views have proven much more profitable models with Web Portals. Craigslist has a history it won’t stray from- FROG is far more ambitious on the profit front, and therefore will eventually make a far better public company than Craigslist ever would.

FROG’s ad placement will allow for both embedded and targeted video, making a better environment for both sellers and buyers.

Limited Trading History With Unlimited Potential

 

FROG recently completed a reverse merger into a shell, and the stock has a very limited trading history. Some of the hottest deals I come across are reverse mergers- if you get clued in before the real campaign begins. With the OTC Journal, unless it’s a follow up on something I’ve already covered, you always get the pole position.

One very comprehensive report I read forecast this stock would trade to $2 to $3 in the next 6 months. From yesterday’s close of $.415, that’s a about a 4 to 6 bagger- 400% to 600% gain on your invested capital.

I’m a little more concerned with what’s likely to happen in the short term. The report I read suggests the stock is a buy up to $.75. Not for OTC Journal subscribers. I believe the top end of your limit should be around $.50.

This stock is going to get a lot of recognition over the coming week- it’s a coming out party, and the fun will just be getting started.

With a stock that hasn’t traded much before, you never know for sure what’s going to happen. Sometimes they simply surge higher than you ever thought they could. Other times they go against you.

With FROG- I believe you can accumulate right up to $.50. Target price in the first 30 days is $1- SSL $.32. I’m looking for a sweet short term double, and who knows from there. If this site just becomes a fraction the size of Craigslist, it could be one of those elusive 10 baggers from about $.40.

Home Page : www.otcjournal.com

Email Questions or Comments To:

editor@otcjournal.com

 


 

Refer
A Friend

If you find the OTC Journal informative
and profitable, please forward our newsletter alert service to like-minded
friends and associates who share similar market interests.


Ensure
Newsletter Delivery

To ensure newsletter delivery, you
can add any additional email
addresses you may have to the OTC Journal Member List. Receiving the OTC
Journal Newsletter in multiple locations is the best way of making sure
you don’t miss the next investing or trading opportunity! For web based
email addresses, the OTC Journal recommends @yahoo.com or @aol.com for
timely and reliable email newsletter delivery.

Note: Your email address will
be kept strictly confidential, and will not be shared with any other entity
for any purpose at any time. If you no longer wish to receive the OTC Journal,
simply follow the instructions located at the bottom of every OTC Journal
Newsletter Edition.

 


 

 

Disclaimer
DISCLAIMERThe OTC Journal Newsletter is an
electronic publication committed to providing our readers with useful information
on publicly traded companies. The Newsletter contracts with publicly traded
companies and receives compensation from them in the form of cash and sometimes
restricted securities as payment for publishing information and opinion
about the company and the trading market for their securities. Principals
of the Newsletter may also purchase or sell securities of the companies
in the open market from time to time. The positions that the Newsletter
or its principals maintain in securities of the companies are disclosed
here (click
here
) and should be considered in making an investment decision regarding
these companies securities.  The Newsletter may be deemed to have
a conflict of interest between its open market activity and positions in
these securities and the timing of and opinions expressed in its publications
concerning these companies.  The publications should not be considered
to be independent publications concerning the company.

All statements and opinions expressed
herein are those of the editors and are subject to change without notice.
The Newsletter maintains editorial control over its publications and the
companies profiled therein do not have any editorial rights concerning
the information published about them. A profile, description, or other
mention of a company in the newsletter is neither an offer nor solicitation
of an offer to buy or sell any securities mentioned. While we believe all
sources of information provided by us and contained in our publication
to be accurate and reliable, we cannot and do not guarantee the accuracy
of information we received from third parties. MarketByte LLC has been pledged a fee of $10,000 by Lake Group Media for coverage of Frogads.

READERS  ARE ENCOURAGED TO DO
THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED IN
THIS PUBLICATION. INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A
HIGH DEGREE OF RISK.

We encourage our readers to invest
carefully and read the investor information available at the web sites
of the Securities and Exchange Commission (“SEC”) at http://www.sec.gov
and/or the National Association of Securities Dealers (“NASD”) at http://www.finra.org.
We also recommend that you read the SEC advisory to investors concerning
Internet Stock Fraud, which can be found at http://www.sec.gov/consumer/cyberfr.htm.
Readers can review all public filings by companies at the SEC’s EDGAR page.
The NASD has published information on how to invest carefully at its web
site.

The information found in this profile
is protected by the copyright laws of the united states and may not be
copied, or reproduced in any way without the expressed, written consent
of the editors of otcjournal.com.

 

You can unsubscribe
from this list at any time by Clicking
Here
. If you are having difficulty removing yourself or wish to change
your address please go to http://www.otcjournal.com/opt/?email=$subst(‘Recip.EmailAddr’).

VRAL- Up 50% Already- More 411

November 22, 2011
Volume XIII, Issue 109

Home Page : www.otcjournal.comEmail Questions or Comments To:
editor@otcjournal.com
To OTC Journal Members: 

This Is Really Big- DCA

 

I’ve done a little more research and I’m now more convinced than ever that yesterday’s penny stock idea- VRAL- has huge upside potential. I’ve looked into this DCA Cancer Therapy a bit further, and gotten a better understanding of the value.

This is my first big winner of the last few ideas, and those that acted on it yesterday are seeing the KACHING!!! Here’s the chart:

VRAL is now up a full 50% from yesterday’s entry level of $.02- as I said- it can be quite easy to notch nice gains in these really low priced ideas.

The market is starting to buzz about yesterday’s DCA announcement. I’ve done my research, and now understand why it’s so big. DCA- Dichloroacetate- is a metabolic disrupter. DCA is a non toxic chemical. It inteferes with the way cancer cells metabolize, and causes them to starve and subsequently die.

A number of major news outlets have covered DCA- accusing Big Pharma of ignoring the potential of DCA as it might be a simple way to treat cancer, and cost big pharma billions.

Evangelos Michelakis, a cancer researcher at the University of Alberta, discovered the compound and had encouraging results in the lab. Dr. Daniel Chang at Stanford Cancer Center is looking at is as well.

The compound was heretofore considered “unpatenable”- and therefore had limited commercial value.

Yesterday’s annoucement, for those that understand it, is huge. Dr. Karen Newell’s use of DCA has been officially granted a patent- US Patent office grant #8,071,646- to be issued on 12/6/2011.

This is huge stuff, particularly when you marry in Marshall Phelps, and advisor to VRAL. Phelps was formerly the Corporate Vice President at Microsoft in charge of Intellectual Property and Licensing.

Now that DCA has a patent, it a license or co development agreement with a major player has a lot of value. Hence, the surge in stock price.

Could be headed for much higher levels.

Home Page : www.otcjournal.com

Email Questions or Comments To:

editor@otcjournal.com

 


 

Refer
A Friend

If you find the OTC Journal informative
and profitable, please forward our newsletter alert service to like-minded
friends and associates who share similar market interests.


Ensure
Newsletter Delivery

To ensure newsletter delivery, you can add any additional email
addresses you may have to the OTC Journal Member List. Receiving the OTC
Journal Newsletter in multiple locations is the best way of making sure
you don’t miss the next investing or trading opportunity! For web based
email addresses, the OTC Journal recommends @yahoo.com or @aol.com for
timely and reliable email newsletter delivery.

Note: Your email address will be kept strictly confidential, and will not be shared with any other entity
for any purpose at any time. If you no longer wish to receive the OTC Journal,
simply follow the instructions located at the bottom of every OTC Journal
Newsletter Edition.

 


 

 

Disclaimer
DISCLAIMERThe OTC Journal Newsletter is an
electronic publication committed to providing our readers with useful information
on publicly traded companies. The Newsletter contracts with publicly traded
companies and receives compensation from them in the form of cash and sometimes
restricted securities as payment for publishing information and opinion
about the company and the trading market for their securities. Principals
of the Newsletter may also purchase or sell securities of the companies
in the open market from time to time. The positions that the Newsletter
or its principals maintain in securities of the companies are disclosed
here (click here) and should be considered in making an investment decision regarding
these companies securities.  The Newsletter may be deemed to have
a conflict of interest between its open market activity and positions in
these securities and the timing of and opinions expressed in its publications
concerning these companies.  The publications should not be considered
to be independent publications concerning the company.

All statements and opinions expressed
herein are those of the editors and are subject to change without notice.
The Newsletter maintains editorial control over its publications and the
companies profiled therein do not have any editorial rights concerning
the information published about them. A profile, description, or other
mention of a company in the newsletter is neither an offer nor solicitation
of an offer to buy or sell any securities mentioned. While we believe all
sources of information provided by us and contained in our publication
to be accurate and reliable, we cannot and do not guarantee the accuracy
of information we received from third parties. MarketByte LLC has been pledged fees of up to $10,000 for coverage of VRAL by Lake Group Media.

READERS  ARE ENCOURAGED TO DO
THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED IN
THIS PUBLICATION. INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A
HIGH DEGREE OF RISK.

We encourage our readers to invest
carefully and read the investor information available at the web sites
of the Securities and Exchange Commission (“SEC”) at http://www.sec.gov
and/or the National Association of Securities Dealers (“NASD”) at http://www.finra.org.
We also recommend that you read the SEC advisory to investors concerning
Internet Stock Fraud, which can be found at http://www.sec.gov/consumer/cyberfr.htm.
Readers can review all public filings by companies at the SEC’s EDGAR page.
The NASD has published information on how to invest carefully at its web
site.

The information found in this profile
is protected by the copyright laws of the united states and may not be
copied, or reproduced in any way without the expressed, written consent
of the editors of otcjournal.com.

 

You can unsubscribe
from this list at any time by Clicking
Here
. If you are having difficulty removing yourself or wish to change
your address please go to http://www.otcjournal.com/opt/?email=$subst(‘Recip.EmailAddr’).

Viral Genetics (VRAL) And Two Nobel Laureates

 

 

November 21, 2011
Volume XIII, Issue 108

Home Page : www.otcjournal.com

Email Questions or Comments To:
editor@otcjournal.com
 

To OTC Journal Members: 

Penny Stock Double Header

 

Another lousy day in the markets. But – wait- perhaps there is some heat out there!!! Investors are loving the little penny stocks- and here’s part II of this week’s double header. Another instance of a situation where you can control a lot of shares while taking only a little risk, and the tiniest of moves will yield very big percentage returns.

POSC was off to the races early- up 20% in the early going on good volume. The stock traded 1 million shares before I even got out of bed.

So, as the markets continue to be obsessed with the global inability of politicians to make the hard choices, we’ll be very happily looking at stocks that have almost no downside, and very strong upside where you can control a lot of stock.

When the markets are rough, investors love these little low priced stocks, and here’s another one in the biotech sector that appears to be ready to charge North.

Today’s idea has major news- it’s added another potential blockbuster therapy to its already extensive portfolio of potential home runs. If they just hit one of these therapies the upside from this level is incalculable and nearly infinite.

Where Can You Find This? Viral Genetics and Two Nobel Laureates

 

You might not believe this, but where can you find a 2 cent stock that boasts two Nobel Laureates on its advisory board- Dr. Luc Montagnier and Dr. Baruch Blumberg serve this little biotech story?

These kinds of companies make for the perfect low priced stocks to own- Why? Because tech breakthroughs in little stocks like this can lead to huge gains in stock price.

Viral Genetics (OTC PK: VRAL) is one of the companies working in a biotech field where major breakthroughs are widely anticipated by the industry.

TPT- Targeted Peptide Technology – is a medical field that is booming. The potential applications include HIV/AIDS, Lyme Disease, and Drug Resistant cancers. In fact, VRAL is already begun crafting its NDAs (New Drug Applications) with the FDA and has applied for early stage testing.

Six international early stage clinical trials have been completed- the trials demonstrated their VGV-X HIV therapy significantly reduced the viral load by 90% to 95% in many patients. Another words- their therapy makes the existing HIV therapies more effective.

With 40 million cases of HIV worldwide, the need to reduce the cost of HIV therapy is in high demand.

Today VRAL announced it’s added a new cancer therapy to its portfolio. Coming out of the University of Colorado (my Alma mater), VRAL today announced it has been granted the exclusive license to develop a compound known as DCA (dichloroacetic acid). DCA is an cancer therapy enhancement compound that accelerates the destruction of tumors without the debilitating side effects of chemotherapy or radiation- see news release below.

Small stocks like this are all about major breakthroughs- one strong announcement on any of the therapies they are working on, and you could see this stock trade up five fold from its low entry level today.

Another Perfect Chart- VRAL Poised To Move

 

The VRAL chart reveals another stock that has hit bottom and is in a rebound phase. A simple return to mid summer levels would yield over 50% return- but I’m looking for much more.

Let’s look at an information packed chart:

Over the last several weeks the multi month downtrend in this stock has reversed course, and the stock is now clearly headed for higher ground. I’m getting really fancy today, and providing a number of technical indicators that support this thesis.

First, after months of decline, it’s obvious the price has come off the oversold bottom- more than doubling over the last several weeks. The rate of incline is also increasing. Secondly, out of nowhere, volume has materialized on this story. Whenever you see this happen, there’s something going on out there people close to the company know about, and this can often be a precursor to a major breakthrough.

Thirdly- the accumulation/distribution line has turned up for the first time in months- at present, there are simply more buyers than sellers in this stock, which bodes well for higher levels.

Lastly is the MACD – The stock is trying very hard to break above the neutral line, and technicians watch this indicator for a surge above the zero line- as you can see, it’s just starting to turn up.

For 2 cents you can own a piece of a company that is developing therapies for a myriad of difficult diseases- HIV/AIDS, Lyme Disease, and a host of others. Human clinical trials have already been conducted on their HIV/AIDS therapy that proved they can get a good result in many cases.

This is a great shot for 2 cents. Someday, you’ll wake up and see this little 2 cent story trading at 10 cents and heading north on a major development. The market is pricing in something like that in the near future.

Here’s today’s news release for your review:

Granting of Patent Marks Milestone on Viral Genetics’ Path Toward Licensing Revenue

Viral Genetics (VRAL) reports that a patent under which it is exclusively licensed, will be granted for using a compound known as DCA to treat cancer. DCA (dichloroacetic acid) has emerged as a compound that accelerates the destruction of tumors without the deleterious and debilitating side effects associated with chemotherapy or radiation. This is the first patent granted for the use of DCA to treat cancer, and represents a significant milestone in the company’s growth.

The United States Patent and Trade Office has announced that the patent calling for the use of Dichloroacetate (DCA) to treat Cancer will be issued to the University of Colorado (CU) – and licensed exclusively to Viral Genetics – as a result of the invention filed by Viral Genetics’ Lead Scientist, Dr. M. Karen Newell Rogers during her tenure at CU. Newell Rogers originally filed the patent application in 2003, based on research work she and colleagues had done relating to “systems and methods for treating human inflammatory and proliferative diseases and wounds, with fatty acid metabolism inhibitors and/or glycolytic inhibitors”. Her work has resulted in the granting of patent number 8,071,645, which will issue on December 6, 2011.

Since filing the application, other companies and research entities, both in the US and internationally, have also done much work to validate and unlock the value inherent in utilizing DCA as a therapeutic agent. Over the last four years, extensive validating research has been performed that documents DCA as a potentially powerful cancer treatment. Dr. Newell Rogers is one of the scientific pioneers suggesting that agents, including DCA, that disrupt tumor specific metabolic pathways, will have value as novel cancer drugs and, as such, she is the first researcher to have a patent granted on its use in the battle against cancer.

Haig Keledjian, Viral Genetic’s CEO, said, “We have been strategically accumulating a significant and valuable portfolio of intellectual property rights around Dr. Newell’s core metabolic disruption science. As we take each step toward monetization of our IP portfolio, this patent, and many others that we anticipate will be granted, are expected to continue to create value for our shareholders. In concert with our legal team, we are setting in place the licensing and revenue strategy for the company from this IP portfolio.”

SAFE HARBOR FOR FORWARD-LOOKING STATEMENTS:

This news release contains forward-looking statements that involve risks and uncertainties associated with financial projections, budgets, milestone timelines, clinical development, regulatory approvals, and other risks described by Viral Genetics, Inc. from time to time in its periodic reports, including statements about its VG Energy, Inc. subsidiary. None of Viral Genetics’ drug compounds are approved by the US Food and Drug Administration or by any comparable regulatory agencies elsewhere in the world, nor are any non-pharmaceutical products of VG Energy, Inc. commercialized. While Viral Genetics believes that the forward-looking statements and underlying assumptions reasonable, any of the assumptions could be inaccurate, including, but not limited to, the ability of Viral Genetics to establish the efficacy of any of its drug therapies in the treatment of any disease or health condition, the development of studies and strategies leading to commercialization of those drug compounds in the United States, the obtaining of funding required to carry out the development plan, the completion of studies and tests on time or at all, the successful outcome of such studies or tests, or the successful commercialization of VG Energy, Inc.’s non-pharmaceutical products. Therefore, there can be no assurance that the forward-looking statements included in this release will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, the forward-looking statements should not be regarded as a representation by Viral Genetics or any other person that the objectives and plans of Viral Genetics will be achieved.

Read the full story at http://www.prweb.com/releases/2011/11/prweb8981224.htm

PRWeb.com

Press Releases: VRAL

Home Page : www.otcjournal.com

Email Questions or Comments To:

editor@otcjournal.com

 


 

Refer
A Friend

If you find the OTC Journal informative
and profitable, please forward our newsletter alert service to like-minded
friends and associates who share similar market interests.


Ensure
Newsletter Delivery

To ensure newsletter delivery, you
can add any additional email
addresses you may have to the OTC Journal Member List. Receiving the OTC
Journal Newsletter in multiple locations is the best way of making sure
you don’t miss the next investing or trading opportunity! For web based
email addresses, the OTC Journal recommends @yahoo.com or @aol.com for
timely and reliable email newsletter delivery.

Note: Your email address will
be kept strictly confidential, and will not be shared with any other entity
for any purpose at any time. If you no longer wish to receive the OTC Journal,
simply follow the instructions located at the bottom of every OTC Journal
Newsletter Edition.

 


 

 

Disclaimer
DISCLAIMER

The OTC Journal Newsletter is an
electronic publication committed to providing our readers with useful information
on publicly traded companies. The Newsletter contracts with publicly traded
companies and receives compensation from them in the form of cash and sometimes
restricted securities as payment for publishing information and opinion
about the company and the trading market for their securities. Principals
of the Newsletter may also purchase or sell securities of the companies
in the open market from time to time. The positions that the Newsletter
or its principals maintain in securities of the companies are disclosed
here (click
here
) and should be considered in making an investment decision regarding
these companies securities.  The Newsletter may be deemed to have
a conflict of interest between its open market activity and positions in
these securities and the timing of and opinions expressed in its publications
concerning these companies.  The publications should not be considered
to be independent publications concerning the company.

All statements and opinions expressed
herein are those of the editors and are subject to change without notice.
The Newsletter maintains editorial control over its publications and the
companies profiled therein do not have any editorial rights concerning
the information published about them. A profile, description, or other
mention of a company in the newsletter is neither an offer nor solicitation
of an offer to buy or sell any securities mentioned. While we believe all
sources of information provided by us and contained in our publication
to be accurate and reliable, we cannot and do not guarantee the accuracy
of information we received from third parties. MarketByte LLC has been pledged fees of up to $!0,000 by Lake Group Media for coverage of Viral Genetics.

READERS  ARE ENCOURAGED TO DO
THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED IN
THIS PUBLICATION. INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A
HIGH DEGREE OF RISK.

We encourage our readers to invest
carefully and read the investor information available at the web sites
of the Securities and Exchange Commission (“SEC”) at http://www.sec.gov
and/or the National Association of Securities Dealers (“NASD”) at http://www.finra.org.
We also recommend that you read the SEC advisory to investors concerning
Internet Stock Fraud, which can be found at http://www.sec.gov/consumer/cyberfr.htm.
Readers can review all public filings by companies at the SEC’s EDGAR page.
The NASD has published information on how to invest carefully at its web
site.

The information found in this profile
is protected by the copyright laws of the united states and may not be
copied, or reproduced in any way without the expressed, written consent
of the editors of otcjournal.com.


Compensation and Other Disclosures

The content of this message is published by Imperial Consulting Network Inc.  and sent to select email lists through Lake Group Media, Inc. (“Lake”) to provide readers with information on selected publicly traded companies. Factual information is obtained from public filings and other sources deemed to be reliable; however, neither Imperial Consulting Network Inc.  nor Lake takes responsibility for verifying the accuracy of such information and they make no representation that such information is accurate or complete. Certain of the statements in this Update may be considered forwarded looking statements. Imperial Consulting Network Inc.  and Lake make no representation and provide no assurance or guaranty that such forward looking statements will prove to be accurate. See the company’s filings with the Securities and Exchange Commission for factors that may cause results to be significantly different. Statements of opinion and belief are those of the authors and/or editors of this Update, and are based solely upon the information possessed by such authors and/or editors; no inference should be drawn that such authors or editors have any special or greater knowledge about the company or companies profiled or any particular expertise in the industries or markets in which the profiled company or companies compete. The reader should verify all claims and complete his own due diligence before investing in any securities of the profiled company or companies. Neither Imperial Consulting Network Inc. , Lake, nor anyone involved in the publication or dissemination of this Update is a registered investment adviser or broker/dealer. Imperial Consulting Network Inc.  and Lake make no recommendation that the purchase of securities of the company or companies profiled in this Update are suitable or advisable for any person or that an investment in such securities will be profitable. In general, given the nature of the company or companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree! of risk. An investor in such securities should be prepared and able to bear a loss of his or her entire investment. Nothing in this Update should be construed as an offer or solicitation to buy or sell any securities of any profiled company. Lake has been retained to provide direct marketing services for the company profiled in this Update and receives compensation for those services. Further, Lake and its employees and affiliates may own, or may purchase and sell, securities of the company or companies profiled. Lake undertakes no obligation to inform readers about the ownership or trading activities of it or its employees or affiliates in the securities of the profiled company or companies. Lake has the following compensation arrangements with the company or companies profiled in this Update: Lake receives an advertising fee ranging from $1,000 to $100,000 for each direct marketing list recommended and ordered for the dissemination of this Update.

You can unsubscribe
from this list at any time by Clicking
Here
. If you are having difficulty removing yourself or wish to change
your address please go to http://www.otcjournal.com/opt/?email=$subst(‘Recip.EmailAddr’).

A Smokin’ Hot Penny Stock: Positron (POSC)

 

November 20, 2011
Volume  XIII, Issue 107

Home Page : www.otcjournal.com

Email Questions or Comments To:
editor@otcjournal.com
 

To OTC Journal Members: 

A Smokin’ Hot Penny Stock: Positron (POSC)

 

Did you wake up today worrying about the global supply of medical radioisotopes? I know I didn’t. Strontium-82 and other medical radionuclides were not the subjects of concern this Sunday morning.

I know it wasn’t foremost on my mind. However, it’s on the mind of penny stock lovers as one small company is making an aggressive move into this sector. One day last week this stock traded 400,000 shares. The next day it traded 37 million shares.

Now, that’s some interest. Oh, and by the way, the day it traded 37 million shares, the stock was up 150% during intraday trading.

Now, I don’t know a lot about medical radionuclides, but I’ve done a little research, and this is cutting edge medical stuff. Here’s the scoop:

Radionuclides are small amounts of nuclear material that can be combined with other elements to form pharmaceutical chemical compounds. These compounds can then be admistered to a patient, and then these nuclear materials attach themselves to diseased tissues internally.

The patient is then treated with a laser targeted radiation- allowing for the destruction of diseased tissues and/or cancerous tumors.

Here’s how this therapy would compare to a military operation. Imagine the Navy Seals sneaking into a Taliban compound and hiding a little homing device. Our Navy ship could than launch a missile, guided by the homing device. The net result- Boom- a bunch of dead bad guys.

Formerly unknown, but now red hot Positron Corp (OTC BB: POSC) announced last week it will be acquiring Manhattan Isotope of Lubbock, Texas. The acquisition is expected to close January 2, 2012.

Apparently, Manhattan Isotope produces the medical radioisotope strontium-82. As a follow up last week, POSC announced Manhattan Isotope will collaborate with French based Arronax to further develop these radio isotopes.

The stock market has loved this series of announcements, and the stock is red hot.

Here’s why it’s time to catch the next run.

Positron (OTC BB: POSC): A Perfect Chart

 

What to see a chart with a perfect entry level?

If you see a stock breakout, and you want to get on board, but you don’t want to buy at the top, use Fibonacci Retracements. Fibonacci, a 12th Century mathematician, identified certain ratios that constantly re occur in nature.

One of the key numbers in the Fibonacci Ratios is 61.8%- measure your arm sometime. If you let your arm hang on the side of your body, I’ll bet then end of your fingers is very close to 61.8% of your height from the ground.

61.8% retracements are ideal entry level. If you take your position, and the stock wants to fall farther, just sell and get out. That stock is not going to bounce.

It might choose to trade sideways for a day or two. If, within a reasonable amount of time, it doesn’t head back up, you know it’s not going to. A 61.8% retracement is about the lowest risk entry point you’ll find for a hot stock.

Here’s the POSC chart. Note early last week the stock was trading at 1.1 cents very quietly. Boom- the news takes the stock from 400k shares one day to nearly 40 million the next day.

Any surge like that is going to be met with a pullback. It’s normal and natural. It’s also going to draw attention, so those that felt they missed the first move might start piling in on the pullback.

The perfect 61.8% retracement from last week’s action for POSC is $.0141- or 1.4 cents. Friday’s last trade was 1.36 cents, so close enough for me.

It’s worth noting a move just to 2 cents yields a 47% return over Friday’s close. Need I say more.

As I said- a perfect little penny stock with a perfect entry level. The odds are in your favor at the open tomorrow. You can own a lot of stock risking very little capital.

Home Page : www.otcjournal.com

Email Questions or Comments To:

editor@otcjournal.com

 


 

Refer
A Friend

If you find the OTC Journal informative
and profitable, please forward our newsletter alert service to like-minded
friends and associates who share similar market interests.


Ensure
Newsletter Delivery

To ensure newsletter delivery, you
can add any additional email
addresses you may have to the OTC Journal Member List. Receiving the OTC
Journal Newsletter in multiple locations is the best way of making sure
you don’t miss the next investing or trading opportunity! For web based
email addresses, the OTC Journal recommends @yahoo.com or @aol.com for
timely and reliable email newsletter delivery.

Note: Your email address will
be kept strictly confidential, and will not be shared with any other entity
for any purpose at any time. If you no longer wish to receive the OTC Journal,
simply follow the instructions located at the bottom of every OTC Journal
Newsletter Edition.

 


 

 

Disclaimer
DISCLAIMER

The OTC Journal Newsletter is an
electronic publication committed to providing our readers with useful information
on publicly traded companies. The Newsletter contracts with publicly traded
companies and receives compensation from them in the form of cash and sometimes
restricted securities as payment for publishing information and opinion
about the company and the trading market for their securities. Principals
of the Newsletter may also purchase or sell securities of the companies
in the open market from time to time. The positions that the Newsletter
or its principals maintain in securities of the companies are disclosed
here (click
here
) and should be considered in making an investment decision regarding
these companies securities.  The Newsletter may be deemed to have
a conflict of interest between its open market activity and positions in
these securities and the timing of and opinions expressed in its publications
concerning these companies.  The publications should not be considered
to be independent publications concerning the company.

All statements and opinions expressed
herein are those of the editors and are subject to change without notice.
The Newsletter maintains editorial control over its publications and the
companies profiled therein do not have any editorial rights concerning
the information published about them. A profile, description, or other
mention of a company in the newsletter is neither an offer nor solicitation
of an offer to buy or sell any securities mentioned. While we believe all
sources of information provided by us and contained in our publication
to be accurate and reliable, we cannot and do not guarantee the accuracy
of information we received from third parties. MarketByte LLC has been pledged a fee of up to $10,000 buy EEA inc for coverage of Positron.

READERS  ARE ENCOURAGED TO DO
THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED IN
THIS PUBLICATION. INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A
HIGH DEGREE OF RISK.

We encourage our readers to invest
carefully and read the investor information available at the web sites
of the Securities and Exchange Commission (“SEC”) at http://www.sec.gov
and/or the National Association of Securities Dealers (“NASD”) at http://www.finra.org.
We also recommend that you read the SEC advisory to investors concerning
Internet Stock Fraud, which can be found at http://www.sec.gov/consumer/cyberfr.htm.
Readers can review all public filings by companies at the SEC’s EDGAR page.
The NASD has published information on how to invest carefully at its web
site.

The information found in this profile
is protected by the copyright laws of the united states and may not be
copied, or reproduced in any way without the expressed, written consent
of the editors of otcjournal.com.

 

You can unsubscribe
from this list at any time by Clicking
Here
. If you are having difficulty removing yourself or wish to change
your address please go to http://www.otcjournal.com/opt/?email=$subst(‘Recip.EmailAddr’).

Attention Penny Stock Lovers

 
November 17, 2011
Volume      XIII, Issue 107

Home Page : www.otcjournal.comEmail Questions or Comments To:
editor@otcjournal.com

To OTC Journal Members: 

A Bit of A Snore

 

Shakespeare said it best- so far, Much Ado About Nothing.

Fledgling oil exploration company American Liberty (OREO), with the exception of one brief blip down, has been a bit of a snore.

$1.20 was about the entry level, and $1.20 is about where the stock is trading today. On Tuesday it briefly blipped down to about $1, and then quickly rebounded.

Since my SSL was about $1, perhaps some of you got “Whipsawed” in the stock- meaning bought, sold on the drop, then watched it quickly bounce. Perhaps some of you didn’t.

Volume has subsided substantially, and the stock has so far been pegged with 5 cents of the entry level.

I hope there’s a another leg up in this stock in the not too distant future. In the meantime, stay disciplined on your stops and your targets.

Honorable Mention Sagebrush Gold (OTC BB: SAGE)

 

Nevada based Sagebrush Gold (SAGE) gets honorable mention for recent price performance.

I covered SAGE back on 9/25 at an entry level of $1.03. The stock hit $1.30 in a couple of trading days, but then headed south for 6 out of 8 days to end up making a bottom at about $.45.

However, since finding its bottom, SAGE has rebounded handsomely- proving that you have to keep watching these stocks as you never know when opportunities will arise.

Here’s how the stock has behaved of late:

Off the bottom of $.45, the stock has nearly doubled in the last 15 trading days. Moral of the story- keep following these things. One never knows.

Attention Penny Stock Lovers

 

Since it seems to be a little tougher to make money in penny stocks, I believe I’m going to feature one or two penny/penny stocks. These stocks are so low they almost can’t go any lower.

It’s worth noting- if you pick up a 1 cent stock and it goes to 1.5 cents, the ROI is no different than a $10 stock going to $15, or a $100 stock going to $150.

Look for a “can’t go any lower” idea soon. If you love a good old fashioned true penny stock, you might like this one.

Home Page : www.otcjournal.com

Email Questions or Comments To:

editor@otcjournal.com

 


 

Refer
A Friend

If you find the OTC Journal informative
and profitable, please forward our newsletter alert service to like-minded
friends and associates who share similar market interests.


Ensure
Newsletter Delivery

To ensure newsletter delivery, you
can add any additional email
addresses you may have to the OTC Journal Member List. Receiving the OTC
Journal Newsletter in multiple locations is the best way of making sure
you don’t miss the next investing or trading opportunity! For web based
email addresses, the OTC Journal recommends @yahoo.com or @aol.com for
timely and reliable email newsletter delivery.

Note: Your email address will
be kept strictly confidential, and will not be shared with any other entity
for any purpose at any time. If you no longer wish to receive the OTC Journal,
simply follow the instructions located at the bottom of every OTC Journal
Newsletter Edition.

 


 

 

Disclaimer
DISCLAIMERThe OTC Journal Newsletter is an
electronic publication committed to providing our readers with useful information
on publicly traded companies. The Newsletter contracts with publicly traded
companies and receives compensation from them in the form of cash and sometimes
restricted securities as payment for publishing information and opinion
about the company and the trading market for their securities. Principals
of the Newsletter may also purchase or sell securities of the companies
in the open market from time to time. The positions that the Newsletter
or its principals maintain in securities of the companies are disclosed
here (click
here
) and should be considered in making an investment decision regarding
these companies securities.  The Newsletter may be deemed to have
a conflict of interest between its open market activity and positions in
these securities and the timing of and opinions expressed in its publications
concerning these companies.  The publications should not be considered
to be independent publications concerning the company.

All statements and opinions expressed
herein are those of the editors and are subject to change without notice.
The Newsletter maintains editorial control over its publications and the
companies profiled therein do not have any editorial rights concerning
the information published about them. A profile, description, or other
mention of a company in the newsletter is neither an offer nor solicitation
of an offer to buy or sell any securities mentioned. While we believe all
sources of information provided by us and contained in our publication
to be accurate and reliable, we cannot and do not guarantee the accuracy
of information we received from third parties.

READERS  ARE ENCOURAGED TO DO
THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED IN
THIS PUBLICATION. INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A
HIGH DEGREE OF RISK.

We encourage our readers to invest
carefully and read the investor information available at the web sites
of the Securities and Exchange Commission (“SEC”) at http://www.sec.gov
and/or the National Association of Securities Dealers (“NASD”) at http://www.finra.org.
We also recommend that you read the SEC advisory to investors concerning
Internet Stock Fraud, which can be found at http://www.sec.gov/consumer/cyberfr.htm.
Readers can review all public filings by companies at the SEC’s EDGAR page.
The NASD has published information on how to invest carefully at its web
site.

The information found in this profile
is protected by the copyright laws of the united states and may not be
copied, or reproduced in any way without the expressed, written consent
of the editors of otcjournal.com.

 

You can unsubscribe
from this list at any time by Clicking
Here
. If you are having difficulty removing yourself or wish to change
your address please go to http://www.otcjournal.com/opt/?email=$subst(‘Recip.EmailAddr’).

Nevada Black Gold- American Liberty (OREO)

 

 

November 13, 2011
Volume XIII, Issue 105

Home Page : www.otcjournal.com

Email Questions or Comments To:
editor@otcjournal.com
 

To OTC Journal Members: 

Black Gold, Texas Tea

 

Ok- They have Texas Tea in Nevada as well. How many readers are old enough to remember the Beverly Hillbillies TV show starring Buddy Ebsen as Jed Clampett?- the reluctant hillbilly turned Beverly Hills millionaire when they discover oil on his mountain property.

“One Day He Was Shooting At Some Food, and up From the Ground Come A Bubbling Crude”.

The Beverly Hillbillies sitcom ran on CBS from 1962 to 1971- coincidentally it was near the end of the show’s run when oil prices went berserk for the first time in the modern era.

Not many people know this, but oil actually sold for over $70 a barrel in 1869- when it was first drilled for. Conventional thinking in 1869 believed there was no way you could stick a drill bit in the ground and find oil. Once drilling started as the technology was available, oil spent the next 100 years between $10 and $20 per barrel as it was easily found in the US.

It was the decade of the 70′s that saw the first major oil shortage, raging inflation, and out of control pricing. Prices started the 70′s decade at about $25 per barrel, and ended at $70 per barrel. By the 70′s we had evolved to a dependence on Middle Eastern oil, and when there were shortages and embargoes, oil prices went berserk.

It was the oil shortages of the 70′s that caused Brazil to go down a path of long term energy independence. We, in the US, instead chose to buddy up to the Shah of Iran and the King of Saudi Arabia to insure our oil supplies.

The Brazilians were smart enough to develop a sensible approach to Ethanol as a fuel additive. You see- in the US we have government mandated Ethanol production in all of our gasoline. This is a giant scam on the American people costing us billions. Our Ethanol industry uses corn to derive the ethanol, and the yields don’t work. It’s a flawed model. It takes far too much corn to produce the required ethanol, and we subsidize the ethanol and corn growers with tax dollars.

The demand for ethanol drives up the price of corn, which in turn drives up the price of feeding livestock, which of course drives up the price of food.

The Ethanol scam is left over from the Bush Administration’s buddying up to Archer Daniels Midland (NYSE: ADM), one of GW’s largest campaign contributors.

Ethanol works in Brazil because it is derived from sugar cane. Ethanol yields from sugar cane are nearly 10 times that of corn, and that model makes economic sense. During 2008 Ford Motor prospered selling its “Flex” vehicle lines in South America while GM was dying. Those vehicles were designed to run on much higher levels of Ethanol.

When the price of oil retreated in the 80′s and 90′s we lost our focus on energy independence. Brazil did not, and look where it got us.

With oil demand ever growing out of Emerging Economies, we are now refocusing on developing domestic supplies.

Demand from emerging nations has oil over $100 per barrel once again, and there’s a lot of rhetoric in the election speak about developing US resources aggressively again. There are 3 states that have very lenient drilling policies- Texas, North Dakota, and Nevada. Looking for work? – I’ve read there’s a need for 2,000 workers today in West North Dakota as the Baaken Shale is expected to eventually add 2 million barrels a day to domestic oil production.

I believe the small oil and gas exploration companies are going to get hot again, and new entrants into the field will be greeted by the market with enthusiasm. So far, on small oil and gas companies I’m 3 out of 4.

I’ve covered three companies in the sector in the last year. Field Point Petroleum (AMEX: FPP) was a big win- trading from $3.00 about a year ago today to $5.50 by March for a 83% gain in 5 months.

Imperial Resources (OTC BB: IPRC) (4/17) was a big win as well. Introduced last May at $.40, the stock found the $.70 level twice by June- yielding a 75% return.

How about Eagle Ford Energy (OTC BB: EFRDF)? $1 in May to $1.80 in June- another 80% win.

Bering Exploration (OTC BB: BERX) was my one winner and loser. First covered on March 31st, the stock cooperated in the short term running from $.80 to $1.60 by the end of April providing OTC Journal readers with a cool 100% gain in the first month.

I stuck with that one a little too long, and it reversed course on me and became a loser.

The track record in the last year is 4 big wins in the sector, and 1 loss. Hence the need to stick with the SSLs- Suggested Stop Losses- minimize the losses, and you are way ahead.

As I pointed out in yesterday’s edition- you have the pole position on this new idea- it’s never traded and no one knows about it. When it becomes a “Crowded Trade”, you can be a seller for a strong profit.

Black Gold in Nevada: American Liberty (OTC BB: OREO)

 

OREO is the new kid on the block, and as promised you are getting the absolute first look.

I’m not going to put up a chart because there’s nothing to see- this stock has never traded. The stock traded a few shares at $1.25, and that’s it. Of course, as I pointed out in yesterday’s edition, there was a time when RAYS had traded zero at $1.25- when the volume came in, it traded to $2.40 in a month before crashing. The early entrants on that ride made a lot of money.

Based in Bakersfield, California, OREO has acquired the rights to drill on two large claims in Nevada: The Gabbs Valley prospect, and the Kibby Flat prospect.

Both of these properties were first looked at and evaluated in 2008. Both were found to have extremely high probabilities for profitable drilling, but the economic climate in 2008 caused the discoveries to be temporarily shelved.

Their Kibby Flats prospect is estimated to contain as much as 669 million barrels of recoverable oil spanning 7270 acres of land.

Their Gabbs Valley prospect is estimated to contain 4+ billion barrels of oil over 26,000 acres.

To learn more about the company and their plans, visit their web site at http://www.americanlibertypetro.com/website.php.

You want to be positioned ahead of certain events in a stock like this. The “Thrill of the Drill” will drive this stock higher in the near future as the company prepares to do some test drilling. Remember, as we learned in past editions- it’s the prospect of doing the test drilling that will push up the price- not the actual event.

You want to be in ahead of the crowd.

Since it’s impossible to make any sort of technical call on this one, set your SSL 15% below your entry level. That seems like a reasonable risk to take.

Let’s look to own this one in the $1.25 range- but you will have to use your judgement when it begins to trade at the open. A gap much above $1.25 should be avoided. $1.30 to- $1.35 should be the max. Based on past experience, I’m looking for the stock to go to $2, but I’ll make adjustments when it begins to trade in earnest, and a chart develops.

Let the fun begin.

Home Page : www.otcjournal.com

Email Questions or Comments To:

editor@otcjournal.com

 


 

Refer
A Friend

If you find the OTC Journal informative
and profitable, please forward our newsletter alert service to like-minded
friends and associates who share similar market interests.


Ensure
Newsletter Delivery

To ensure newsletter delivery, you
can add any additional email
addresses you may have to the OTC Journal Member List. Receiving the OTC
Journal Newsletter in multiple locations is the best way of making sure
you don’t miss the next investing or trading opportunity! For web based
email addresses, the OTC Journal recommends @yahoo.com or @aol.com for
timely and reliable email newsletter delivery.

Note: Your email address will
be kept strictly confidential, and will not be shared with any other entity
for any purpose at any time. If you no longer wish to receive the OTC Journal,
simply follow the instructions located at the bottom of every OTC Journal
Newsletter Edition.

 


 

 

Disclaimer
DISCLAIMER

The OTC Journal Newsletter is an
electronic publication committed to providing our readers with useful information
on publicly traded companies. The Newsletter contracts with publicly traded
companies and receives compensation from them in the form of cash and sometimes
restricted securities as payment for publishing information and opinion
about the company and the trading market for their securities. Principals
of the Newsletter may also purchase or sell securities of the companies
in the open market from time to time. The positions that the Newsletter
or its principals maintain in securities of the companies are disclosed
here (click
here
) and should be considered in making an investment decision regarding
these companies securities.  The Newsletter may be deemed to have
a conflict of interest between its open market activity and positions in
these securities and the timing of and opinions expressed in its publications
concerning these companies.  The publications should not be considered
to be independent publications concerning the company.

All statements and opinions expressed
herein are those of the editors and are subject to change without notice.
The Newsletter maintains editorial control over its publications and the
companies profiled therein do not have any editorial rights concerning
the information published about them. A profile, description, or other
mention of a company in the newsletter is neither an offer nor solicitation
of an offer to buy or sell any securities mentioned. While we believe all
sources of information provided by us and contained in our publication
to be accurate and reliable, we cannot and do not guarantee the accuracy
of information we received from third parties. MarketByte LLC has been paid a fee of $10,000 for coverage of American Libety by Winning Media.

READERS  ARE ENCOURAGED TO DO
THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED IN
THIS PUBLICATION. INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A
HIGH DEGREE OF RISK.

We encourage our readers to invest
carefully and read the investor information available at the web sites
of the Securities and Exchange Commission (“SEC”) at http://www.sec.gov
and/or the National Association of Securities Dealers (“NASD”) at http://www.finra.org.
We also recommend that you read the SEC advisory to investors concerning
Internet Stock Fraud, which can be found at http://www.sec.gov/consumer/cyberfr.htm.
Readers can review all public filings by companies at the SEC’s EDGAR page.
The NASD has published information on how to invest carefully at its web
site.

The information found in this profile
is protected by the copyright laws of the united states and may not be
copied, or reproduced in any way without the expressed, written consent
of the editors of otcjournal.com.

 

You can unsubscribe
from this list at any time by Clicking
Here
. If you are having difficulty removing yourself or wish to change
your address please go to http://www.otcjournal.com/opt/?email=$subst(‘Recip.EmailAddr’).